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ABSTRACT 
Objectives: Despite relatively high asthma prevalence, little is known about the epidemiology 
of asthma among Native Hawaiian/Other Pacific Islanders (NHOPI), or the roles of 
socioeconomic factors in asthma disparities among NHOPI. 
Methods: Multivariable logistic regression using 2001-2010 Behavioral Risk Factor 
Surveillance System data was conducted to provide adjusted lifetime and current asthma 
prevalence estimates and ratios, within groupings by sex and self-identified census categories of 
race for the overall US population, as well as separately for the US state of Hawai‘i. Asthma 
prevalence disparities by race were also investigated within groupings by sex and indicators of 
socioeconomic status (SES). The comparative abilities of risk factors to predict asthma within 
strata by race or SES were investigated using dominance analysis. 
Results: Asthma prevalence markedly differed between groupings by sex and race, with those 
self-identifying as NHOPI frequently having the highest point estimates of ever-diagnoses and 
current asthma. There was evidence of excess asthma in Hawai‘i compared to other US regions, 
especially among White women and Asians. Sociodemographic factors predictive of adult 
asthma prevalence varied by both sex and race. Women often had higher asthma prevalence 
than males of the same race, but the degree to which sex modified asthma prevalence differed by 
race, sociodemographic characteristic, and/or socioeconomic status. There were consistent 
dose-response declines in asthma prevalence with increasing SES only among Whites and 
women of race other than NHOPI, White, or Asian. Asthma was most frequent among NHOPI 
within some lower and upper levels of SES. Asthma disparities by race were modified by sex and 
SES; stratification by SES attenuated associations between asthma and race. However, some 
asthma disparities by race persisted after controlling for SES, including for NHOPI and in 
comparison with Asians. The dominant factors predictive of adult asthma prevalence depended 
on sex and race, as well as education attainment. 
iv 
Conclusions: The distribution of asthma in the US is not socially equitable and instead 
depends on race and/or SES. The findings of this work call for greater considerations in asthma 
studies regarding interactions between race and social factors and provide a baseline with which 
to plan and compare other prevention programs, epidemiological investigations, and 
surveillance for asthma.  
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 Asthma is an incurable chronic inflammatory disease of the respiratory system 
characterized by difficulty breathing, with episodes that can vary in severity. Episodes of 
wheezing from this disorder of the airways can become acute and life-threatening. Asthma can 
also substantially diminish quality of life, although symptoms can often be mitigated by patient 
education, pharmacotherapy, and/or avoidance of triggers (1-4). As a condition of complex 
etiology, asthma has many causative factors that interact. However, many risk factors for 
asthma are preventable such as obesity, smoking, viral infections, poor air quality (both indoor 
and outdoor), stress, and occupational exposures  (1, 5-10).  
 There is no ‘gold standard’ for the diagnosis of asthma and so asthma surveillance and 
population-level epidemiologic studies typically rely on self-report. Estimates of asthma 
prevalence have gradually increased over the past half century in developed countries (11), 
becoming a very common disease in the US with 14% of adults reporting an asthma diagnosis in 
2016 (12). Asthma is also common among US children and more so among boys (9.2%) than 
girls (7.4%), with prevalence that increased between 2001-2010 (8, 13). Indeed, asthma is 
considered an epidemic in the US, but prevalence varies geographically at both broad regional 
and local community scales (5, 8, 12). Although childhood asthma often persists into adulthood 
(14), asthma associations with sex reverse with age such that asthma is more common among 
adult women than men (8, 15-17). Unusual for a chronic disease, adult current asthma 
prevalence is inversely associated with age such that lowest prevalence is observed among those 
65 years or older (8, 18). In addition, asthma is much more prevalent among adults who are of 
young age (18-34 years), obese, smokers, and/or who have lower levels of socioeconomic status 
(SES) as indicated by less education, lower income, or unemployment (5-8, 12, 13, 18-27). 
Asthma prevalence can also be associated with aspects of healthcare, particularly when 
surveillance is via the self-report of a diagnosis from a medical provider. 
 The burden of the asthma epidemic also varies by race/ethnicity. Lowest asthma 
prevalence in the US is usually found among Asians and Mexican Americans, while non-
Hispanic Blacks and Hispanics of Puerto Rican descent often report asthma more frequently 
than Whites (8, 12, 13, 18, 25, 28-30). However, geographic and/or sociodemographic predictors 
of asthma can depend on race (26, 31-46), while racial asthma disparities are in turn often 
conditional on SES (19, 24, 46-49). Reducing asthma has long been a US national priority, 
including as an objective of the US Healthy People framework (50, 51). However, the asthma 
xvi 
epidemic and its associated social/racial disparities have continued unabated or worsened (5, 8, 
12, 20, 30, 52). 
 Asthma is especially common among indigenous peoples (8, 29), including Native 
Hawaiian/Other Pacific Islanders (NHOPI) (26, 53, 54). NHOPI are a small (1.4 million in the 
US in 2016) but growing population of those identifying their race as including ancestry in the 
indigenous peoples of Hawai‘i or other Pacific islands (39, 55, 56). Many potentially preventable 
diseases and sequelae are disproportionately prevalent among NHOPI including some cancers, 
cardiovascular disease, diabetes, mortality across the lifespan, and overall fair/poor health (26, 
34, 36, 53, 54, 57, 58). In the US Pacific island state of Hawai‘i, where over a third of US NHOPI 
reside (56), about 20% of NHOPI adults have reported an asthma diagnosis (26, 53). In 
conjunction, and like many other racial populations more impacted by asthma (33, 39, 42, 43), 
NHOPI are also more likely to report lower measures of socioeconomic status (SES) such as less 
education, lower income levels, and unemployment (26, 34, 39, 41, 44).  
 However, health surveillance specifically for NHOPI has been lacking, with disease 
prevalence and incidence estimates difficult to obtain due to the common practice of aggregating 
NHOPI with Asians. As a result, there remains little known about NHOPI asthma prevalence. 
Moreover, the burden of asthma among NHOPI may be underestimated due to notably low 
asthma prevalence among Asians. Standards instituted in the US in 1997 that require separation 
of NHOPI and Asian racial categories are now enabling discovery and documentation of health-
related characteristics of NHOPI. 
 It has long been recognized that SES strongly predicts many health outcomes, regardless 
of race: Disease incidence, morbidity, and mortality rates are typically worse in populations of 
the lowest SES. Moreover, the relationship between comparatively lower SES and worse health 
is often independent of poverty status or threshold income levels; even among the middle/upper 
classes, there can be a dose-response between relative SES gain and better health outcomes (59-
61). However, relationships between socioeconomics and health can vary by race, with some 
racial groups experiencing fewer health benefits from improved SES (62-65). There is now 
growing recognition that socioeconomic factors combine with racialized categories to play a 
predominant but complex role in US health inequities (66-69), including those observed for 
asthma outcomes (19, 24, 46, 48). Indeed, interactions between SES and race should be 
expected, given that race is itself a complex socioeconomic and political construct without a 
biological basis (70, 71).  
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 Lower SES measures are frequently associated with both asthma (5, 8, 12, 13, 18, 19, 22-
24) and the racial populations that manifest higher asthma prevalence (33, 39, 42, 43), while 
many factors that can affect asthma incidence and/or severity (e.g., sex, age, body mass index 
(BMI), smoking, and healthcare) also covary with both SES and race (31-33, 35-40, 45, 49, 72). 
Despite the inclusion of these myriad socioeconomic and demographic potential confounders in 
many multivariable investigations, racial differences in the burden of asthma have been 
repeatedly shown to persist. That is, differences in common measures of SES and other 
population demographics have not simply explained US racial disparities in asthma (19, 24, 26, 
28, 29, 46).  
 Thus, this dissertation is motivated by the need for further investigations that document 
and explore the relationships between race, SES, and other sociodemographics – especially in 
the context of long-standing and egregious health inequities by racial/social groupings in the US 
such as those that persist for asthma. The primary aim of the studies herein is to provide social 
epidemiologic findings regarding asthma prevalence in the US that may contribute to asthma 
prevention. An additional objective is to provide baseline (2001-2010) asthma surveillance 
information that will be useful to contemporary and future health disparity studies as 
environmental, social, and socioeconomic conditions change in the US. Lastly, this dissertation 
contributes an applied example of a methodological approach (i.e., dominance analysis) that is 
not commonly utilized in epidemiology but that can provide useful insights into complex 
systems phenomena such as social/racial disparities in asthma. Together, fulfillment of these 
objectives contributes to knowledge that will help to inform efforts that seek to eliminate health 
disparities and achieve health equity. 
 Human Subject Protections  
 These studies were classified as exempt by the University of Hawai‘i at Mānoa 
Institutional Review Board. 
 Inclusion of Previously Published Material  
 I previously investigated adult asthma prevalence disparities by race in the US using 
multiple years of Behavioral Risk Factor Surveillance System (BRFSS) survey data, with a focus 
on Native Hawaiian/Other Pacific Islander (NHOPI), in partial fulfillment of the requirements 
for the degree of Master of Science in Public Health at the University of Hawai‘i at Mānoa (73). 
Additionally, as a primary author I similarly investigated asthma prevalence disparities and 
sociodemographic associations with asthma by race within Hawai‘i, with published results (26). 
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These investigations motivated the more in-depth studies of this dissertation. Chapter 1 is 
similar to the work of my Master’s thesis, but differs by: 1) Including additional BRFSS data (i.e., 
2010); 2) excluding Alaska (due to small sample sizes for some strata); and 3) aggregating some 
racial groups (i.e., Black/African American and American Indian/Alaska Native, to enable 
inclusion of data from Hawai‘i in stratifications and multivariable modeling for NHOPI 
estimates). Chapter 2 includes material from the previously published manuscript. However, 
Chapters 1 and 2 both differ from previous work by: a) Including additional adjustment 
covariates (i.e.,US census region, healthcare provider, and healthcare utilization); b) excluding 
an SES indicator covariate (to enable comparisons of subsequent model results with this factor); 
c) providing adjusted prevalence estimates using improved statistical models.  
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STUDY 1: ASTHMA PREVALENCE DISPARITIES AND DIFFERENCES IN 
SOCIODEMOGRAPHIC ASSOCIATIONS WITH ASTHMA AMONG NATIVE 
HAWAIIAN/OTHER PACIFIC ISLANDER, ASIAN, AND WHITE RACE IN THE 
UNITED STATES 
INTRODUCTION 
 This study investigated the racial and sociodemographic factors involved in the US adult 
asthma epidemic during the decade between 2001-2010, with intent to address asthma 
knowledge gaps specifically regarding those who identify as Native Hawaiian/Other Pacific 
Islander (NHOPI).  
 The primary study aim was to document a nationwide baseline of the burden of asthma 
among NHOPI, as well as to investigate and describe national-level asthma disparities by race, 
as compared to Asians. That is, this study asked, ‘Has asthma prevalence been elevated among 
NHOPI compared to Asians, Whites, and those of Other races in the US?; how has asthma 
prevalence differed among racial groups in the US, including NHOPI?’  
 The second objective of this study was to compare the magnitudes of asthma associations 
with sociodemographic factors among NHOPI, Asians, and Whites, and those of Other race, 
after controlling for multiple sociodemographic covariates. That is, this study asked, ‘Within 
groupings by sex and race, how strong were associations with asthma for each of several known 
sociodemographic asthma risk factors (i.e., region, time period, age, BMI, smoking, healthcare 
coverage, and healthcare provider)?; are these asthma associations of the same strength 
regardless of sex and race, or does sex/race modify associations with asthma prevalence?’ 
 Lastly, this investigation sought to describe geographic heterogeneity in asthma 
prevalence, with control for potential confounders. Specifically, this study sought to answer the 
question, ‘Has there been excess asthma in the US state of Hawai‘i?; among groupings by sex 
and race, is asthma prevalence different in Hawai‘i than in the overall US population?’ 
 Together these objectives will provide a comparative context for subsequent studies of 
the epidemiology of asthma within Hawai‘i, including asthma among NHOPI in Hawai‘i. To my 
knowledge, this is the first investigation to provide an in-depth characterization of asthma 
among NHOPI by examining nationwide multivariable-adjusted asthma prevalence estimates, 
with comparisons of adjusted asthma prevalence and potential asthma predictors by groupings 
of sex and race. 
2 
METHODS  
 Data Source 
 A sample size sufficient to meet the study aims for the relatively small NHOPI 
subpopulation in the US was uniquely available from multiple years of Behavioral Risk Factor 
Surveillance System (BRFSS) health survey data. Lifetime and current asthma prevalence 
among adults (≥ 18 years) living in households with telephones in the US was assessed using 
2001 through 2010 BRFSS data. BRFSS is a continuous random-digit-dialed telephone health 
survey, conducted by US states in partnership with the Centers for Disease Control and 
Prevention (CDC), in which sociodemographic and health characteristics are self-reported. The 
BRFSS annual datasets were obtained from the CDC public website (http://www.cdc.gov/brfss) 
and included weights that permit statistical inferences to national/state-level populations and 
that reduce estimate bias from non-coverage and non-response.  
 Questions about asthma have been part of the core BRFSS survey since 2001. To provide 
sufficient sample sizes, nine years of BRFSS from 2001 through 2010 were aggregated; data 
were not available for year 2004 for Hawai‘i and so all 2004 data were excluded. BRFSS data 
beyond year 2010 were not included due to changes in the survey’s sampling design in 2011 that 
complicate comparability with earlier time periods. Data from the non-continental US other 
than Hawai‘i were excluded (i.e., Alaska, Guam, Puerto Rico, and the US Virgin Islands) due 
either to very small numbers of NHOPI in these geographic regions or to disparate 
environmental/social conditions not sufficiently described by available covariates. 
 Dependent Variables – Lifetime and Current Asthma  
 Outcome variables were chosen from the two BRFSS questions regarding asthma 
prevalence: 1) Lifetime asthma, defined as a ‘yes’ answer to the question, ‘Have you ever been 
told by a doctor, nurse, or other health professional that you had asthma?’ and 2) Current 
asthma, defined as a ‘yes’ answer to the follow-up question, ‘Do you still have asthma?’ 
Frequency of missing for these outcome variables was less than 1%. 
 Independent Variables - Race 
 Race classification was derived from the questions, ‘Which one or more of the following 
would you say is your race?’, and if multiple races were indicated, ‘Which one of these groups 
would you say best represents your race? (US census categories available for selection: White; 
Black or African American; Asian; Native Hawaiian or Other Pacific Islander (NHOPI); 
3 
American Indian or Alaska Native; Other; Don’t know/Not sure)’. Survey respondents not best 
identifying as either NHOPI, White, or Asian were classified as Other race (including those not 
answering or indicating “Don’t know/Not sure”); an analysis category solely for Black or African 
American race was not included due to its very small sample size in Hawai‘i and this 
investigation’s focus on NHOPI. 
 Independent Variables – Sociodemographics 
 In addition to sex (female/male), US Census region (i.e., respondent’s state designated as 
in Hawai‘i, West, Midwest, South, or Northeast (74)), and three-year time period (2001-2003, 
2005-2007, or 2008-2010), other sociodemographic covariates were selected for analysis if they 
were available for every year and had a known association with asthma. Age responses were 
grouped into three categories for sufficient sample sizes (18-34, 35-64, ≥ 65 years). Categories 
for body mass index (BMI; weight/height2) were assigned using CDC definitions (not 
overweight/obese, BMI < 25; overweight (OW), 25 ≤ BMI < 30; obese (OB), BMI ≥ 30). A 
smoking status of ‘never’ was defined as a ‘no’ answer to the question, ‘Have you smoked at least 
100 cigarettes in your entire life?’; if ‘yes’, a respondent was categorized as an ‘ever-smoker’. 
Possession of healthcare coverage was derived from the question, ‘Do you have any kind of 
health care coverage, including health insurance, prepaid plans such as HMOs, or government 
plans such as Medicare?’. Having ready access to healthcare was assessed with the question, ‘Do 
you have one person you think of as your personal doctor or health care provider?’. A proxy for 
healthcare utilization within the past two years was derived from the question, ‘About how long 
has it been since you last visited a doctor for a routine checkup?’ (not asked in 2003; data for 
this variable were excluded from the 2001-2003 time period). Frequency of missing for each of 
the above covariates was less than 1.5%, except for BMI which had a frequency of missing of 4%.  


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Statistical Analyses 
 Analyses were conducted using the dataset of the entire continental US plus Hawai‘i. All 
statistical analyses were conducted using SAS-callable SUDAAN (version 11.0; RTI 
International, Raleigh, NC), accounting for the complex sampling design of BRFSS. SUDAAN’s 
‘subpopx’ statement was used to define subpopulations, and Taylor series linearization was used 
for variance estimation. For inferences to the state and regional levels, annual survey weights 
were made equally proportional (i.e., were divided by the number of aggregated years). 
All strata with a numerator of N < 25 were excluded from analyses. Coefficients of variation 
(COV), which quantify sampling variability of an estimator, were calculated using SAS 
‘Surveyfreq’ (version 9.4; SAS Institute, Cary, NC) to confirm asthma prevalence estimate 
reliability (i.e., COV < 30%) for denominator strata having small sample sizes (N < 100).  
 Logistic regression models of asthma prevalence were fit to the subset 2005-2010  
dataset for the covariate of healthcare utilization; otherwise models were fit to the entire 2001-
2010  dataset. The sociodemographic covariates of region, time period, age, BMI, smoking 
status, and healthcare provider remained significant (p-value < 0.05) in multivariable models 
using the overall US population, and so were retained in all models. Although not always 
statistically significant, healthcare coverage was also retained in all models due to its possible 
importance as a potential confounder within some strata. To rule out the presence of multi-
collinearity in multivariable models, the SAS procedure ‘proc reg’ was used for the calculation of 
collinearity tolerance estimates. Final analyses were conducted separately for women and men 
because sex strongly modifies many asthma associations (15, 21, 26). In addition, because 
asthma is known to vary greatly by geographic region (5, 8, 12),  two-way interactions between 
region and each of the other covariates were tested together within all sex/race strata, with 
significant interactions retained in the final model. The multivariable model was not run for 
current asthma among male NHOPI due to insufficient sample sizes or the Midwest region. 
 Because odds ratios from a logistic regression model will overestimate the strength of 
association when the outcome is not rare, model-adjusted prevalence ratios (aPRs) from 
predicted marginals were instead used to quantify and assess associations (75, 76). Such 
estimates can be more easily interpretable than probability odds, while permitting comparisons 
of the predicted outcome among groups after controlling for the differences in the distributions 
of the covariates. Moreover, predictive margins with survey data readily enable assessment of 
group effects on the outcome when interactions are present in the model (76). Briefly, predicted 
marginals adjust for covariate differences among groups in a way similar to traditional 
epidemiologic standardization, by computing the predicted prevalence for a particular group 
7 
using the group’s own risk of the outcome for each covariate but given the covariate distribution 
of the remaining population. That is, aPRs answer the question, ‘What would the prevalence be 
in this subgroup, if the subgroup had the covariate distribution of all others in the sample?’ 
 Prevalence ratios were conservatively considered significant when 95% confidence 
intervals (CI) excluded 1.0, and differences between prevalence estimates and prevalence ratios 
were considered meaningful when CIs did not overlap. Data visualizations were conducted using 
Tableau (version 10.5). 
RESULTS   
  Racial and Sociodemographic Diversity in the United States 
 The combined continental US and Hawai‘i BRFSS dataset for 2001-2010 was comprised 
of 3,078,504 records, of which 12,475 identified as NHOPI (Table 1.2). Over 74% of the survey 
responses from those identifying as NHOPI, and 58% from Asian, originated in Hawai‘i or 
western states (Table 1.3). Over half (52%) of responses by those of Other race were from the 
South, while responses from Whites were more evenly distributed regionally (Table 1.4). Among 
those categorized as Other race, 62% identified as Black or African American outside of Hawai‘i 
and the Western region, compared to 24% and 35% in Hawai‘i and the West, respectively 
(Appendix Table 5.1). While 54% percent of BRFSS records for NHOPI were from Hawai‘i, the 
largest weighted population size estimate for NHOPI was from the continental US Western 
region. Weighted population sizes were largest in the South for Whites and those of Other Race, 
but the Asian population was largest in the West.  
 Compared with Whites and Asians of the same sex, NHOPI were more often male and 
younger, and reported lack of healthcare coverage or provider more frequently (Tables 1.3 and 
1.4, and Appendix Tables 5.2 thru 5.5). Asthma risk factors of obesity and ever-smoking were 
more common among NHOPI and Whites than among Asians. Obesity was more common 
among NHOPI, White, and Asian males than females of the same race, and males of all races 
also reported lack of healthcare coverage or a provider more often than females. Ever-smoking 
was most frequently reported by Whites and least frequently reported by Asians, but regardless 
of race smoking was more common among males than females. While Whites reported having a 
personal healthcare provider most frequently, women of Other race were the most likely to have 
recently utilized healthcare. Those of Other race also reported the largest population 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Overall Asthma Prevalence and Associations in the United States 
 In the overall US population, the crude prevalence of having ever been diagnosed with 
asthma was 12.6%, and prevalence of currently having asthma was 8.0% (Table 1.2). However, 
asthma prevalence varied by sociodemographic characteristic. For example, both lifetime and 
current asthma prevalence estimates were independently and strongly associated with female 
sex, obesity, and having a healthcare provider. Asthma prevalence was also consistently and 
independently associated with all other sociodemographic covariates except healthcare coverage 
(i.e., US regions other than the South, the latter two time periods, younger age (< 65 years), 
ever-smoking, and healthcare utilization); crude prevalence of current, but not lifetime, asthma 
was related to having health care coverage.  
 Asthma Prevalence Disparities By Race in the United States 
 Those identifying as NHOPI had the highest unadjusted prevalence estimates for lifetime 
asthma (16.5%), and much higher prevalence of current asthma (8.7%) than Asians (4.2%) 
(Table 1.2). Compared to Asians, prevalence of current asthma was greatly elevated among both 
NHOPI and those of Other race (PR=2.1), as well as for Whites (PR=1.9). Having ever had a 
diagnosis of asthma was twice as common among NHOPI (PR=2.0) compared to Asians 
(P%=8.4%), while lifetime asthma was also much more frequent among those of Other race 
(PR=1.6) and Whites (PR=1.5).  
 However, racial disparities in asthma prevalence were modified by sex (Tables 1.5). For 
example, both lifetime and current asthma were much more common among Whites and those 
of Other race than among Asians, but more so for women than for men. Similarly, crude lifetime 
asthma prevalence was elevated among women (14.3%) compared to men (10.8%), as was 
current asthma (10.0% among women, 6.0% among men), but asthma associations with sex 
were modified by race (Table 1.6). For example, women were significantly more likely than men 
to report current asthma, but more so for NHOPI, Whites, and Other race than Asian women.  
15 
Table 1.5. United States, by sex or race - Lifetime asthma crude prevalence and 
unadjusted race/sex associations with lifetime asthma - Behavioral Risk Factor 
Surveillance System, 2001-2010.   
United States  Associations 
between 
asthma and race 
Associations 
between 
asthma and sex 









Race: NHOPI 17.6 (15.5,19.9) 2.0 (1.7,2.3) 1.1 (0.9,1.4) 
Race: White 14.1 (14.0,14.2) 1.6 (1.5,1.7) 1.3 (1.3,1.3) 
Race: Other 15.7 (15.4,15.9) 1.8 (1.7,1.9) 1.4 (1.3,1.4) 
Race: Asian 8.8 (8.1,9.4) 1.0 (ref) 1.1 (1.0,1.2) 









Race: NHOPI 15.7 (13.2,18.6) 1.9 (1.6,2.4) 1.0(ref) 
Race: White 10.7 (10.6,10.9) 1.3 (1.2,1.5) 1.0(ref) 
Race: Other 11.4 (11.0,11.7) 1.4 (1.3,1.5) 1.0(ref) 




Table 1.6. United States, by sex or race - Current asthma crude prevalence and 
unadjusted race/sex associations with current asthma - Behavioral Risk Factor 
Surveillance System, 2001-2010. 
United States  Associations 
between 
asthma and race 
Associations 
between 
asthma and sex 









Race: NHOPI 11.2(9.5,13.1) 2.3(1.9,2.8) 1.6(1.3,2.2) 
Race: White 9.9(9.8,10.0) 2.1(1.9,2.3) 1.6(1.6,1.7) 
Race: Other 11.1(10.9,11.4) 2.3(2.1,2.6) 1.8(1.7,1.9) 
Race: Asian 4.8(4.3,5.3) 1.0(ref) 1.3(1.1,1.5) 










Race: NHOPI 6.8(5.5,8.4) 1.8(1.4,2.3) 1.0(ref) 
Race: White 6.0(5.9,6.1) 1.6(1.4,1.8) 1.0(ref) 
Race: Other 6.3(6.0,6.5) 1.7(1.5,1.9) 1.0(ref) 




 Asthma in the United States Among Women and Men, By Race 
 After stratifying by sex and race and controlling for other covariates within each sex/race 
grouping, meaningful increases in asthma prevalence with time were greater among males than 
females (Tables 1.7 thru 1.14). Asthma ever-diagnoses were especially more frequent among 
Asian men in 2008-2010 compared to 2001-2003 (aPR=1.4). Increased adjusted lifetime 
asthma prevalence during the latter time periods was statistically significant for NHOPI men in 
2005-2007 but not 2008-2010. Current asthma prevalence was 20% more prevalent among 
White men in 2008-2010 than in 2001-2003. However, large confidence intervals for NHOPI 
asthma estimates, and insufficient sample size for current asthma among NHOPI men, limited 
inferences for this racial grouping. 
 Young age (18-34 years) was strongly associated with asthma among Whites and those 
categorized as Other race, and much more so among men than women for lifetime asthma 
(Tables 1.7 thru 1.14). Among Asians, lifetime asthma, but not current asthma, was also higher 
among those reporting young age compared to the eldest age group (≥ 65 years).  
 There were meaningful associations between obesity and asthma among all races 
regardless of sex, with stronger associations among White and Other race women compared to 
men of the same race (Tables 1.7 thru 1.14). Lifetime asthma was more strongly associated with 
obesity among Asian men (aPR=2.0), than among White (aPR=1.2) or Other race (aPR=1.1) 
men. Moreover, current asthma was more strongly associated with obesity than lifetime asthma 
for White and Other race women, and marginally more so for NHOPI and all Asians. 
Associations between obesity and current asthma were strongest for Asians (e.g., aPR=2.5 Asian 
women, aPR=2.2 Asian men), and were meaningfully greater than for Whites and Other race of 
the same sex. Overweight BMI was associated with elevated asthma prevalence as compared to 
normal BMI only among women, but especially for Asian women; current asthma was more 
strongly associated with overweight among Asian women (apR=1.7), than among White 
(apR=1.2) or Other race (aPR=1.1) women. 
 Asthma prevalence was elevated among ever-smokers compared to never-smokers, 
except among Asian men, and more so for women than men: Reports of an asthma ever-
diagnosis and/or current asthma were more common among White, Other race, and Asian 
women reporting ever-smoking than among men (Tables 1.7 thru 1.14). Among Asian women 
the association between ever-smoking and asthma was uniquely somewhat less for current than 
for lifetime asthma. 
 Associations between having healthcare coverage and asthma prevalence, after 
controlling for other covariates, were meaningfully demonstrated only among females of NHOPI 
18 
or Other race (Tables 1.7 thru 1.14). However, healthcare coverage associations with asthma 
were marginally also present among Asians. In contrast, having healthcare coverage was not 
associated with asthma among Whites. Both lifetime and current asthma were consistently more 
common among those having a healthcare provider, except among NHOPI men reporting 
lifetime asthma. Recent healthcare utilization was meaningfully associated with asthma 
prevalence among White and Other race men reporting current asthma. However, smaller 
sample sizes for the healthcare utilization covariate (data available for 2005-2010 only) likely 
reduced power to detect differences within some strata. 
 Geographic Associations with Asthma Prevalence, By Sex and Race 
 Both lifetime and current asthma were reported least frequently in the South, with 
asthma ever-diagnoses about 10% more common in the West, Midwest, and Northeast (Table 
1.2). Unadjusted prevalence of lifetime asthma, but not current asthma, was higher in Hawai‘i 
than in any other region in the US, with prevalence about 20% higher than in the South (i.e., 
P%=14.7% in Hawai‘i; P%=11.9% in the South). Lifetime asthma prevalence was associated with 
the West (P%=13.3%), Midwestern (P%=12.5%), and Northeastern (P%=13.1%) regions of the 
US, compared to the South. Current asthma was more common in the Midwest (P%=8.4%) than 
in either the West (P%=8.1%) or Hawai‘i (P%=8.0%), but current asthma was reported most 
often in the Northeast (P%=8.8%; PR=1.2, compared to the South). 
 However, geographic patterns of asthma prevalence depended on type of asthma as well 
as race and/or sex, including after controlling for other covariates (Tables 1.7 thru 1.14). For 
example, among NHOPI women adjusted asthma prevalence was substantially higher in Hawai‘i 
or the West compared to the South; NHOPI women in Hawai‘i were 60% more likely to have 
had an asthma ever-diagnosis than in the South, and 2.5 times more likely to report current 
asthma. Moreover, point estimates of lifetime asthma prevalence were higher for NHOPI 
women and men residing in Hawai‘i or the West than for those in the Northeast. Among White 
women, asthma prevalence was highest in Hawai‘i than any other region of the US; among 
White men, lifetime but not current asthma was higher in Hawai‘i or the West than in the other 
US regions. Among Asians an asthma ever-diagnosis was strongly associated with residence in 
Hawai‘i, with adjusted lifetime asthma higher in Hawai‘i than in the Midwest or Northeast. 
 Adjustment for covariates within sex/race groupings often somewhat altered 
associations between asthma and some characteristics (Tables 1.7 thru 1.14). However, 
attenuation of prevalence ratios was never more than 20%, except for the estimates of asthma 
prevalence among NHOPI women in Hawai‘i compared to the US South, and for the estimates of 
current asthma prevalence among NHOPI and Asian women with healthcare coverage. In 
19 
addition, some crude asthma prevalence estimates were potentially negatively confounded by 
more than 20%, such as asthma prevalence among young (18-34 years) Asian and Other race 
women. Despite these instances of changes by 20% or more between crude and adjusted asthma 
prevalence estimates by sex and race, there were only a few meaningful differences: Among 
Whites and those of Other race, estimates of both lifetime and current asthma prevalence were 
substantially higher after adjustment for age 18-34 compared to the oldest age grouping; among 
White men, the association between having healthcare coverage and lifetime asthma was 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 This study provides nationwide baseline estimates of asthma prevalence among NHOPI 
in the US during the decade between 2001 and 2010. These estimates demonstrate that asthma 
prevalence has been greatly elevated among NHOPI women and men compared to Asians. 
Moreover, asthma ever-diagnoses were not only more prevalent among NHOPI compared to 
Asians but were also more common for NHOPI than for Whites or those of Other race. This 
work is consistent with previous findings that asthma prevalence has been higher overall among 
NHOPI (54, 77). In addition, by demonstrating numerous differences of substantial magnitude 
between Asian and NHOPI sociodemographics and asthma prevalence estimates, this work 
demonstrates the importance of disaggregating NHOPI and Asian subpopulations in health 
studies (77, 78).  
 This investigation also found that the strengths of associations with various 
sociodemographic asthma risk factors has varied by race, after controlling for the other 
covariates. That is, associations with asthma for each of several known sociodemographic risk 
factors (i.e., region, time period, age, BMI, smoking, healthcare coverage, and healthcare 
provider) are different amongst racial groupings, as well as by sex. These findings of sex/race 
modifications to associations with asthma prevalence calls for the inclusion of such interactions 
when controlling for the effects sociodemographic differences across racial groupings. 
 Consistent with other US cross-sectional investigations, univariate associations with 
lifetime and current asthma prevalence were observed for the factors of female sex, age younger 
than 65 years, obesity, and smoking (8, 18, 25, 29, 49). Also in agreement with other studies, 
asthma prevalence as measured by these BRFSS data had increased with time (8, 25). Some of 
these congruent previous findings made use of other US health surveys such as the National 
Health Interview Survey (8, 25, 29), the National Health and Nutrition Examination Survey 
(18), and the Hawai‘i Health Survey (54), which lends validity to the BRFSS data utilized by this 
investigation.  
 Also consistent with many other studies, strong associations with elevated asthma 
prevalence were observed for female sex. Many mechanisms may be involved in the well-
documented differences in asthma prevalence and severity between women and men (15), 
including findings that women more frequently possess health insurance and access medical 
care than do men (79, 80). However, this study also found that female sex was not a predictor of 
lifetime asthma for all races: Uniquely, Asian women reported lifetime asthma more often than 
men in only one sociodemographic category, ever-smoking. These findings contribute 
observations that elevated asthma prevalence among women compared to men varied by race in 
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the US. Thus, better understanding is needed regarding race-specific asthma risk factors among 
women. 
 This study found that obesity was universally associated with asthma regardless of 
sex/race. Furthermore, adjusted asthma prevalence was much higher for obese women 
compared to obese men of the same race, except among Asians and NHOPI. However, Asian 
women reporting overweight BMI had higher adjusted current asthma than overweight Asian 
men. These findings are consistent with other studies that have suggested an important and 
gender-mediated relationship between elevated BMI and asthma sequelae (21, 81). 
 A key finding of this investigation is excess asthma in the US state of Hawai‘i, especially 
among White women and all Asians. Small sample sizes limited inferences for NHOPI, but 
asthma prevalence was somewhat more elevated for NHOPI living in Hawai‘i than in the 
Southern or Northeastern US. 
 Besides modest sample sizes in some strata, this study has other limitations. The self-
reported nature of BRFSS survey data could result in response and information bias. However, 
self-reported measures in BRFSS have demonstrated high reliability and validity (82). 
Moreover, self-reported lifetime asthma has demonstrated good positive predictive value and 
specificity, but lower sensitivity (83-85). Thus, bias in self-reported asthma is likely toward 
undercounting those in the population who truly have asthma, which is the desired bias 
direction in studies examining asthma correlates. Another limitation of this study is possible 
information bias from race misclassification. However, if racial misclassification in this study 
was non-differential, bias would likely be towards the null. Lastly, another limitation of this 
study is the lack of a covariate for SES, which is an important and likely effect modifier and/or 
confounder. Similarly, other covariates important for predicting asthma and likely also highly 
correlated with the chosen dependent variables, were not available for inclusion in this study. 
For example, better measures of aspects of healthcare access, usage, and quality could 
potentially alter the adjusted magnitudes of associations with asthma described herein. 
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STUDY 2: ASTHMA PREVALENCE DISPARITIES AND DIFFERENCES IN 
SOCIODEMOGRAPHIC ASSOCIATIONS WITH ASTHMA AMONG NATIVE 
HAWAIIAN/OTHER PACIFIC ISLANDER, ASIAN, AND WHITE RACE IN HAWAI‘I 
INTRODUCTION 
 It has been previously noted that asthma prevalence is relatively high in the state of 
Hawai‘i (86, 87), and that NHOPI in the US bear a disproportionate burden of asthma 
compared to other racial groups (53, 54). In study 1 above, elevated asthma prevalence in 
Hawai‘i compared to some other US regions was observed to persist within some sex/race 
groups after multivariable adjustment for the potential sociodemographic confounders of 
geographic region, time period, age, BMI, smoking, healthcare coverage, and healthcare 
provider, plus any significant interactions between these covariates and region. Moreover, 
study 1 confirmed that asthma prevalence has been relatively high among NHOPI during the 
decade between 2001-2010, with some racial differences in sociodemographic associations with 
asthma.   
 The US state of Hawai‘i is very racially diverse, with an ethnocultural history and 
demographic composition that is unique in the US (55), due in part to its unique geographical 
position in the Pacific. Hawai‘i is also distinct in having the largest percentages in the nation of 
NHOPI (56) and those identifying as Asian (88). Despite these unique sociodemographic 
characteristics, the asthma epidemic in Hawai’i has received very little investigative attention.  
 This second study investigated the racial and sociodemographic factors involved in the 
adult asthma epidemic specifically in Hawai‘i, with intent to address asthma knowledge gaps 
regarding NHOPI and the distinctive multi-ethnic population of Hawai‘i. The first aim was to 
determine asthma sociodemographic associations present in Hawai‘i, and then to compare the 
burden of asthma among the predominant racial groups of Hawai‘i, including NHOPI. The 
second objective was to compare across races the associations between asthma and 
sociodemographic factors, after multivariable adjustment for potential confounders. The final 
study aim was to assess whether asthma prevalence, racial disparities, and/or associations 
among sex/race groupings differ between Hawai‘i versus the continental US population.  
 To my knowledge, this is the first investigation to provide an in-depth characterization of 
asthma specific to Hawai‘i and to NHOPI in Hawai‘i, using multivariable-adjusted estimates 
within sex/race subgroups. 
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METHODS 
 The data source, outcome variables, independent covariates, and statistical analyses 
were the same as for study 1, except that data included survey responses only from the US state 
of Hawai‘i. Adjusted current asthma prevalence among NHOPI men, as well as adjusted lifetime 
and current asthma among Other race women and men, could not be reliably estimated due to 
insufficient sample sizes in some strata from Hawai‘i. 
RESULTS 
 Racial and Sociodemographic Diversity in Hawai‘i 
 There was a total of 54,103 BRFSS records from the state of Hawai‘i, surveyed from 2001 
through 2010 (Table 2.2). The racial demography of Hawai‘i was markedly different than that 
observed in study 1 for the continental US population (Table 2.1); only 6.2% of the weighted 
adult population in Hawai‘i did not best identify as either NHOPI (13.8%), Asian (46.0%), or 
White (34.0%). Sample sizes for Black/African American or American Indian/Alaska Native in 
Hawai‘i were too small for stratified or multivariable analyses and so were grouped within Other 
race (Appendix Table 5.6). Of those classified as Other race from Hawai‘i, 23.8% identified as 
Black/African American and 7.1% as American Indian/Alaska Native; the racial makeup of the 
Other race category in Hawai‘i was markedly different than in the continental US population 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 There were many differences between racial groups in Hawai‘i in regard to 
sociodemographic characteristics of potential importance to asthma prevalence (Tables 2.3 and 
2.4, and Appendix Tables 5.7 thru 5.10). Obesity was conspicuously prevalent in the NHOPI 
subpopulation, and NHOPI also reported younger age more frequently than Asians or Whites. 
Asians had the greatest proportions of age over 65 years, not overweight/obese BMI, and 
nonsmoking, whereas NHOPI and Whites had the highest frequencies of smoking. Those 
categorized as Other race reported age over 65 years least frequently.  
 Sociodemographic characteristics by race were different in Hawai‘i compared to the 
continental US (Tables 2.3 and 2.4 versus Tables 1.3 and 1.4). For example, NHOPI and Asians 
reported young age (18-34 years) more often in the US overall compared to in the US state of 
Hawai‘i, but reported obesity and smoking much more often in Hawai‘i. Healthcare coverage or 
having a healthcare provider was also more common among NHOPI and Asians who resided in 
Hawai‘i, likely due in part to the Hawai‘i Prepaid Health Care Act. However, among all racial 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Overall Asthma Prevalence and Associations in Hawai‘i 
 In Hawai‘i the 2001-2010 overall crude prevalence of ever having been diagnosed with 
asthma was 14.7%, and prevalence of currently having asthma was 8.0% (Table 2.2). However, 
asthma prevalence increased with time and varied across sociodemographic strata. For example, 
both lifetime and current asthma prevalence estimates were independently and strongly 
associated with younger age (< 65 years), obesity, and NHOPI race. Asthma was also more 
common among women than men, and among ever-smokers than never-smokers. Healthcare 
coverage did not predict asthma prevalence, while having either a healthcare provider or recent 
healthcare utilization did predict current asthma in Hawai‘i. 
 Asthma prevalence was higher in Hawai‘i (Table 2.2) than in the continental US 
population (Table 1.2), regardless of race: All racial groupings exhibited elevated lifetime and 
current asthma prevalence in Hawai‘i when compared to prevalence estimates by race from the 
US overall. However, NHOPI and Asians were especially more likely than other races to have 
had an ever-diagnosis of asthma in Hawai‘i compared to elsewhere in the US. Moreover, asthma 
prevalence increased more with time in Hawai‘i than in the US: Overall lifetime asthma 
prevalence in Hawai‘i increased to 16.9% in 2008-2010, and current asthma to 9.5%, which 
consisted of 40% increases from the 2001-2003 baseline. In contrast, asthma increased by about 
10% in the overall US population between the same two time periods. Similarly, magnitudes of 
asthma associations were stronger in Hawai‘i for young age and obesity than in the continental 
US. However, asthma associations with female sex and ever-smoking were not different between 
Hawai‘i and the mainland US population. Similarly, relationships between aspects of healthcare 
and asthma prevalence were also not substantially modified by residence in Hawai‘i, although 
near-universal healthcare coverage in Hawai‘i limited comparisons for some strata.  
 Asthma Prevalence Disparities By Race in Hawai‘i 
 Among the predominant racial groups in Hawai‘i, those identifying as NHOPI had the 
highest crude asthma prevalence estimates for both lifetime (P%=20.9%) and current 
(P%=12.2%) asthma (Table 2.2). Overall lifetime asthma prevalence estimates were not 
demonstrably different between Asians (P%=13.3%), Whites (P%=14.0%), and those of Other 
race (P%=14.7%). Asians had the lowest current asthma prevalence (P%=6.6%), while current 
asthma prevalence estimates were not demonstrably different between Whites (P%=8.1%) or 




 However, racial disparities in asthma prevalence in Hawai‘i differed between sexes; 
asthma disparities by race were greater among women, except for NHOPI (Tables  2.5 and 2.6). 
Similarly, current asthma was strongly associated with female sex within all racial 
subpopulations, but the strength of the association was not consistent among the different racial 
groupings. 
Table 2.5. Hawai‘i, by sex or race - Lifetime asthma crude prevalence and 
unadjusted race/sex associations with lifetime asthma - Behavioral Risk Factor 
Surveillance System, 2001-2010.   
Hawai‘i  Associations 
between 
asthma and race 
Associations 
between 
asthma and sex 









Race: NHOPI 22.9 (21.2,24.8) 1.7 (1.5,1.9) 1.2 (1.1,1.4) 
Race: White 17.1 (16.2,18.1) 1.3 (1.2,1.4) 1.5 (1.4,1.7) 
Race: Other 18.3 (16.0,20.9) 1.4 (1.2,1.6) 1.6 (1.2,2.0) 
Race: Asian 13.4 (12.6,14.2) 1.0 (ref) 1.0 (0.9,1.1) 










Race: NHOPI 18.7 (16.6,21.0) 1.4 (1.2,1.6) 1.0(ref) 
Race: White 11.2 (10.3,12.1) 0.8 (0.8,0.9) 1.0(ref) 
Race: Other 11.6 (9.5,14.1) 0.9 (0.7,1.1) 1.0(ref) 




Table 2.6. Hawai‘i, by sex or race - Current asthma crude prevalence and 
unadjusted race/sex associations with lifetime asthma - Behavioral Risk Factor 
Surveillance System, 2001-2010.   
 
  
Hawai‘i  Associations 
between 
asthma and race 
Associations 
between 
asthma and sex 









Race: NHOPI 15.6 (14.1,17.2) 2.1 (1.8,2.4) 1.9 (1.5,2.3) 
Race: White 11.2 (10.5,12.1) 1.5 (1.3,1.7) 2.1 (1.9,2.5) 
Race: Other 11.9 (10.0,14.0) 1.6 (1.3,1.9) 2.4 (1.7,3.4) 
Race: Asian 7.5 (6.9,8.2) 1.0 (ref) 1.3 (1.2,1.6) 









Race: NHOPI 8.4 (7.0,10.1) 1.5 (1.2,1.9) 1.0(ref) 
Race: White 5.3 (4.7,5.9) 0.9 (0.8,1.1) 1.0(ref) 
Race: Other 5.0 (3.6,6.7) 0.9 (0.6,1.2) 1.0(ref) 
Race: Asian 5.6 (5.0,6.4) 1.0 (ref) 1.0(ref) 
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Asthma in Hawai‘i Among Native Hawaiians/Other Pacific Islander 
Women and Men 
 Overall crude lifetime asthma prevalence among NHOPI in Hawai‘i was 60% higher than 
for Asians, and current asthma prevalence was 80% higher (Table 2.2). After stratification by 
sex and adjustment for potential confounders, such disparities were substantially reduced for 
NHOPI men with lifetime asthma, but not for NHOPI women with either lifetime or current 
asthma (Tables 2.5 and 2.6).  
 Sociodemographic associations with asthma prevalence among NHOP were modified by 
sex (Tables 2.7 and 2.8). For example, 28.6% of obese NHOPI women reported lifetime asthma 
compared to 21.1% of obese NHOPI men, whereas 21.0% of obese NHOPI women reported 
current asthma compared to 10.0% of obese NHOPI men. Similarly, NHOPI women who were 
ever-smokers had substantially higher asthma prevalence than NHOPI men with the same 
smoking status, including after adjustment. 
 There was increased lifetime asthma prevalence with time among NHOPI men in 
Hawai‘i (aPR=1.6; 2008-2010 versus 2001-2003) after adjustment for other covariates, but not 
among NHOPI women (Tables 2.7 and 2.8). Among NHOPI men, adjusted lifetime asthma 
prevalence was strongly associated with young age (aPR=2.8; 18-34 versus ≥ 65 years). Obesity 
strongly predicted lifetime and current asthma among NHOPI women but not lifetime asthma 
among NHOPI men. For example, after controlling for covariates NHOPI women with obese 
BMI were 70% more likely to report current asthma than NHOPI women with a BMI that was 
not categorized as overweight/obese. In addition, smoking was associated with both lifetime 
(aPR=1.3) and current (aPR=1.4) asthma among NHOPI women but not men. Having a 
healthcare provider was marginally associated with asthma for NHOPI women, but small 




 Within nearly all sociodemographic categories, asthma prevalence was higher among 
NHOPI women and men residing in Hawai‘i compared to the continental US population, 
although differences were not always statistically significant (Tables 1.7, 1.8, 2.7, and 2.8). The 
magnitudes of adjusted sociodemographic associations with asthma were similar between the 
Hawai‘i and the continental US population of women NHOPI. Among NHOPI men, the 
association between young age (< 65 years) and an asthma ever-diagnosis was somewhat greater 
in Hawai‘i, whereas lifetime asthma associations with obesity and smoking were somewhat 
stronger in the overall US population compared to in Hawai‘i alone. Also, for nearly all 
sociodemographic categories, adjusted lifetime and current asthma prevalence point estimates 
were higher among NHOPI women (Figure 1) and men (Figure 2) than among Whites and 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Asthma in Hawai‘i Among Asian Women and Men 
 Lower asthma prevalence among Asians compared to Whites was observed in the 
Hawai‘i population only among women (Tables 2.9, 2.10, 2.11, and 2.12). Furthermore, across all 
racial groups asthma prevalence estimates were lowest among women identifying as Asian 
within many sociodemographic categories. In contrast, point estimates of lifetime asthma 
prevalence were sometimes higher for Asian than for White men, although this racial difference 
was statistically significant only in the categories of overweight BMI and not having a healthcare 
provider. Current asthma prevalence was not demonstrably different between men of Asian or 
White race in any sociodemographic category. 
 Asian women in Hawai‘i demonstrated higher lifetime asthma prevalence than Asian 
men only in the categories of mid-age (35-64 years) and ever-smoking (Tables 2.9 and 2.10). In 
contrast, prevalence of current asthma was consistently higher for Asian women than men 
within many sociodemographic categories. For example, 14.8% of obese Asian women reported 
current asthma, compared to 8.4% of obese Asian men. Similarly, prevalence of current asthma 
among Asian women ever-smokers was 10.2%, compared to 5.7% among Asian male current or 
former smokers.  
 Among all Asians regardless of gender, young age (18-34 years) and obesity were 
associated with adjusted lifetime and current asthma (Tables 2.9 and 2.10). Among Asian 
women, but not Asian men, ever-smoking was associated with lifetime (aPR=1.4) and current 
(aPR=1.6) asthma after controlling for other covariates. Asthma prevalence increased with time 
among Asian women in Hawai‘i, but not among Asian men. No meaningful associations between 
asthma and aspects of healthcare were observed among Asian women and men, but small 




 Asthma was much more common among Asians residing in Hawai‘i (Tables 2.9 and 2.10) 
compared to those in the continental US population (Tables 1.9 and 1.10), for all 
sociodemographic categories and regardless of sex. However, this modification of asthma 
prevalence by Hawai‘i residence was somewhat greater for Asian women than men, and also 
varied by sociodemographic characteristic and type of asthma. For example, an asthma ever-
diagnosis was significantly more common for Asian women with obesity (P%=21.7%) or ever-
smoking (P%=17.1%) who resided in Hawai‘i than those in the mainland US (P%=14.7% and 
P%=12.8%, respectively); for Asian men with obesity or ever-smoking lifetime asthma was 18.1% 
and 12.5% respectively in Hawai‘i, compared to 15.3% and 7.4% in the US. Current asthma 
prevalence in the youngest age group (18-34 years) was at least twice as high among Asians in 
Hawai‘i than in the continental US, regardless of sex. After controlling for other covariates 
among Asian women and men, young age was markedly and more strongly associated with 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Asthma in Hawai‘i Among White Women and Men 
 Female sex was more strongly associated with current asthma among Whites (PR=2.1) 
than among Asians (PR=1.3) (Table 2.6), and lifetime asthma prevalence was also elevated more 
for women compared to men among Whites (PR=1.5) than among Asians (PR=1.0) (Table 2.5). 
Moreover, disparities in asthma prevalence between White women and men were demonstrated 
in nearly all sociodemographic strata examined (Tables 2.11 and 2.12). For example, 18.4% of 
obese White women reported current asthma, compared to 8.5% of obese White men; 
prevalence of current asthma among White overweight women was 11.1%, but was just 4.6% 
among White overweight men.  
 Obesity was strongly associated with current asthma among Whites of both genders 
(Tables 2.11 and 2.12), and more for lifetime asthma among White women than men. 
Associations between asthma prevalence and smoking were not demonstrated among White 
men, but among White women current smoking predicted both lifetime (aPR=1.1) and current 
asthma (aPR=1.2). Young age (18-34 years) was strongly associated with lifetime asthma 
prevalence for Whites regardless of gender (aPR=1.7), while this younger age category predicted 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 2.1. Hawai‘i, Women - Adjusted lifetime and current asthma prevalence, by 
race and sociodemographic characteristics - Behavioral Risk Factor Surveillance 




Figure 2.2. Hawai‘i, Men - Adjusted lifetime and current asthma prevalence, by 
race and sociodemographic characteristics - Behavioral Risk Factor Surveillance 







Asthma in Hawai‘i Among Women and Men of Races Other Than NHOPI, 
Asian, or White 
 Due to small sample sizes for those in Hawai‘i not best identifying as either NHOPI, 
Asian, or White, there was reduced power to detect differences in asthma prevalence for those of 
Other race, and insufficient sample sizes for multivariable adjustment within this racial category 
(Tables 2.13 and 2.14, and Appendix Table 5.10). However, those of Other race did demonstrate 
lower overall crude asthma prevalence compared to NHOPI, regardless of gender. Moreover, 
those of Other race had crude asthma prevalence estimates lower than NHOPI of the same 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 A key finding from this investigation is the markedly high adjusted asthma prevalence 
among NHOPI compared to the other racial groups predominant in Hawai‘i, with persistence of 
elevated NHOPI asthma prevalence within many gender-specific sociodemographic strata 
(Figures 2.1 and 2.2). In addition, by demonstrating numerous differences of substantial 
magnitude between Asian and NHOPI demographics and asthma prevalence estimates, this 
work further demonstrates the importance of disaggregating NHOPI and Asian subpopulations 
in health studies, including in Hawai‘i (77, 78).  
 Other US cross-sectional studies have reported that current asthma prevalence is lower 
among Asians than Whites (25, 29). This study found that in Hawai‘i this was only true among 
women, for both lifetime and current asthma and within many sociodemographic categories; 
among males in Hawai‘i, the asthma prevalence point estimates were instead often lower for 
Whites than for Asians.  
 Consistent with other US cross-sectional investigations, as well as with study 1 for the US 
population overall, this investigation found univariate associations with lifetime and current 
asthma prevalence in Hawai‘i for the factors of female sex, age younger than 65 years, obesity, 
and smoking (8, 18, 25, 29, 49). Also in agreement with other studies, lifetime and current 
asthma estimates were higher overall among NHOPI (54, 77), and asthma prevalence in Hawai‘i 
had increased with time (8, 25).  
 Also consistent with many other studies, as well as study 1, female gender was observed 
to be a strong predictor of current asthma prevalence for the predominant races in Hawai‘i. 
Congruent with the findings of study 1 for the US overall population, in Hawai‘i sex modified 
associations with asthma to a much lesser degree among Asians: Lifetime asthma was elevated 
among Asian women compared to men only for ever-smokers. In Hawai‘i, the Asian 
subpopulation had the largest proportion of nonsmokers; Asians who do or did smoke were 
more often male, but only female Asian ever-smokers had elevated asthma prevalence compared 
to nonsmokers. Lack of asthma associations with smoking among Asian men might be explained 
by modest sample sizes. However, similar gender disparities among NHOPI and White smokers 
were also observed. Together these findings are congruent with biological mechanisms by which 
smoking could cause more asthmatic disease in women than men (89).  
 This study found that in Hawai‘i obesity was universally associated with asthma among 
women regardless of race, was associated with an asthma ever-diagnosis among Asian men, and 
was associated with current asthma among White men. Furthermore, adjusted current asthma 
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prevalence was consistently much higher for obese women compared to obese men of the same 
race. These findings, together with similar findings from study 1 for the overall US population, 
are consistent with other studies that have suggested an important and gender-mediated 
relationship between elevated BMI and asthma sequelae (21, 81). 
 This investigation was limited to covariates available in the BRFSS survey; other 
potentially important confounders were not included in our multivariable model. For example, 
volcanic gas on Hawai‘i Island has been shown to be associated with respiratory problems that 
could influence self-reported asthma, such as cough, acute pharyngitis, wheezing, bronchitis, 
and/or other acute airway problems (90-94). Volcanic emissions dramatically increased in 2008 
and have persisted (93, 94), with public perception and concerns over air quality on the most 
populated Hawaiian island (Oahu) and on Hawai‘i Island. Other relevant environmental 
exposures not herein addressed include sugar cane harvesting by burning (95) and indoor air 
quality associated with tropical climate and/or dampness including household molds and 
cockroaches (86). Second-hand smoke exposure is yet another potentially important covariate 
for studies of asthma prevalence in Hawai‘i. It has been observed that compared to other races 
in Hawai‘i, NHOPI are more likely to live in a household with a smoker, are least likely to 
disallow smoking in the home, and are more likely to have ridden in a car during the past week 
with someone smoking (96). Finally, multivariable adjustments in this study did not a covariate 
representing socioeconomic status which is likely plays important and complex roles in asthma 
disparities in Hawai‘i. 
 Another limitation of this study is possible information bias from race misclassification. 
For those who indicated that NHOPI best represented their race, 72% had indicated more than 
one census race category when initially asked about their race (with 41% specifying two races, 
and 30% specifying three). For those categorized in this study as Other race, when initially asked 
about their race 35% either didn’t know or refused to answer, while 29% specified two races and 
7% specified three races. In contrast, only 14% identifying best as White and 12% identifying 
best as Asian had initially indicated multiple race categories. The identities of the multiple racial 
groups that respondents specified were not included in the utilized BRFSS dataset, and thus the 
heterogeneous nature especially of the NHOPI, Asian, and other race groups in Hawai‘i could 
not be addressed by this study. However, as noted for study 1, if racial misclassification in this 
study was non-differential then bias would likely be towards the null. 
 In summary, sociodemographic associations with adult asthma prevalence in Hawai‘i 
were similar to those reported for other US populations, for the decade between 2001 and 2010. 
The burden of asthma in Hawai‘i by population proportion has been highest among NHOPI, but 
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by absolute population numbers asthma has affected more Asians than any other racial group in 
Hawai‘i. In addition, these findings demonstrate both socially- and racially-specific aspects to 
the epidemiology of asthma in Hawai‘i, which may be important for state-level prevention 
programs such as the Hawai‘i Asthma Plan (87).  However, additional study is needed to better 
assess predictors of asthma prevalence in Hawai‘i, especially among those less frequently 





STUDY 3: SOCIOECONOMIC STATUS AND ASTHMA PREVALENCE DISPARITIES 
AMONG NATIVE HAWAIIAN/OTHER PACIFIC ISLANDER, ASIAN, AND WHITE 
ADULTS IN THE UNITED STATES 
INTRODUCTION 
 Investigations of asthma disparities among racial groups must account for interactions 
between race and SES. Otherwise, the roles of potentially modifiable social determinants of 
asthma will remain poorly understood and the goals for reductions in health inequities unmet.  
 Studies 1 and 2 demonstrated that for NHOPI in the continental US and Hawai‘i, during 
the decade between 2001-2010, asthma prevalence was distinctly high even after controlling for 
several common asthma risk factors. It has also been previously shown that asthma prevalence 
estimates remain elevated among NHOPI after controlling for SES as represented by education 
attainment (26, 53). However, such adjustment utilizing only main effects would insufficiently 
control for SES if the association between asthma and the SES measure varies by race. 
Moreover, it is unlikely that a single SES measure would sufficiently capture the multifarious 
and complex socioeconomic conditions that likely parallel racially-aligned disparities in asthma 
prevalence. Therefore, it remains unknown what and how socioeconomic factors may be 
involved in the unusually high asthma prevalence among US NHOPI. To begin to address this 
question for the continental US plus Hawai‘i, this investigation aimed to determine: 1) Whether 
there are socioeconomic gradients with asthma prevalence in the US that vary by race among 
NHOPI, Asians, Whites, and those of Other races, and 2) If NHOPI and other racial disparities 
in asthma prevalence persist, and/or how they change, after better controlling for differences in 
a variety of different SES measures. 
METHODS 
 The data source, outcome variables, independent covariates, and statistical analyses 
were the same as for study 1, except that the data and analyses included BRFSS responses 
representative of socioeconomic status: 
 Independent Variables – Socioeconomics 
 Variables tenably representative of socioeconomics (97) that were consistently available 
in the multi-year BRFSS datasets were education attainment, household income category, 
household size (defined as the total number of adults and children in the household), 
employment status, and healthcare cost barrier as follows: 
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1) This investigation consolidated education responses into three categories, for 
proportionate sample sizes across categories (less than high school graduation; high 
school graduate (or some college); college graduate).  
2) Categories of annual household income were combined into seven groups such that 
sample sizes were sufficient in the lowest income groups (< $15K, $15K – $24K, $25K – 
$34K, $35K – $49K, $50K – $74K, ≥ $75K, or missing).  
3) To account for both income and household size, categories of annual individual income 
were created by dividing the midpoint of the response household income category by 
household size; individual income level was re-categorized into one of seven groupings 
(< $5K, $5K – $9K, $10K – $14K, $15K – $19K, $20K – $34K, ≥ $35K, or missing).  
4) To help account for both possible monetary resource threshold effects and differences in 
cost of living across time and geography, household income and size were combined into 
a poverty income ratio (PIR). PIR was defined as the midpoint of the response household 
income category divided by the survey year’s poverty guideline based on household size 
for either continental US or Hawai‘i residents (published annually by the US Department 
of Health and Human Services). PIR categories were chosen to achieve sufficient sample 
sizes in the lowest and highest groupings (< 1, 1 – 1.9, 2 – 2.9, ≥ 3, missing).  
5) To explore SES as a composite of both education and monetary resources, three 
groupings were created in the same manner as Karlamangla, et al. 2010 (98): Low SES 
(education less than high school graduation and PIR < 2); High SES (college graduate 
and PIR ≥ 2 ); and Mid SES (all other education and PIR combinations).  
6) Employment status was classified as either: 1) Employed or self-employed; 2) Out of or 
unable to work (herein referred to as ‘unemployed’); or 3) Other (including homemaker, 
student, or retired).  
7) Lastly, having a cost barrier to healthcare utilization was assessed from the question, 
'Was there a time during the last 12 months when you needed to see a doctor, but could 
not because of the cost?' (not asked in 2002; data for this variable were excluded from 
the 2001-2003 time period).  
Frequencies of missing for education, employment, and healthcare cost barrier were less than 
1%. In contrast, frequency of missing was high for household income (14%) and so missing was 
treated as a separate category for income, PIR, and composite SES. Table 3.1 summarizes the 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































  To investigate whether associations between SES and asthma prevalence were modified 
by race, data were stratified by both sex and race. Adjusted lifetime and current asthma 
prevalence ratios for each of the seven different SES measures were obtained from multivariable 
logistic regression models fit within each sex/race subpopulation as described in study 1: 
Included covariates were categories for region, time period, age, BMI, smoking status, 
healthcare coverage, and healthcare provider (Table 2.1) and models were fit using the entire 
2001-2010 dataset, with one exception: Due to missing data in the earliest time period, the 
associations between asthma and having a cost barrier to healthcare were derived from model 
fits that used the subset 2005-2010 dataset and additionally included a covariate for recent 
healthcare utilization. Linear trend tests were used to test for a gradient in asthma prevalence 
from low to high levels of ordinal SES indicators (i.e., education attainment, household and 
individual annual income, PIR, and composite SES; excluding missing). Given observed 
differences in the covariate distributions among SES groupings (data not shown) and known 
interactions between asthma risk factors and SES, plus known geographical heterogeneity in 
asthma prevalence, two-way interactions between the SES measure and each of the other 
covariates were tested together and in conjunction with the inclusion of two-way interactions 
between region. Final adjusted prevalence ratio estimates were derived from a model that 
retained significant interactions with SES and/or region.  
 Similarly, to investigate whether associations between race and asthma prevalence were 
modified by SES, data were stratified by both sex and levels of a socioeconomic indicator. In this 
manner, associations between race and asthma were directly adjusted for SES using 
stratification, instead of using interaction terms in a multivariable model; stratification was 
chosen for clarity and ease of interpretations. Due to observed interactions between race and a 
number of the covariates as described in studies 1 and 2 and the literature, two-way interactions 
between race and each of the other covariates were tested together and in conjunction with the 
inclusion of two-way interactions between region. Final adjusted prevalence ratio estimates 
were derived from a model that retained significant interactions with race and/or region. 
 As in study 1, the multivariable model was not run for current asthma among male 





 Sample and Population Characteristics: SES By Race in the United States 
 The sociodemographic characteristics of the sample and US population were described 
in study 1 (Table 2.2). The sample and population characteristics for the covariates potentially 
representative of SES included in this study are shown in Table 3.2. 
 Compared with Whites and Asians of the same sex, NHOPI reported lack of healthcare 
coverage, unemployment, and a cost barrier to healthcare more frequently, and also had smaller 
proportions within the uppermost strata of the SES indicator variables of education, income, 
and composite SES (i.e., college graduate, individual annual income ≥ $35K, PIR ≥ 3, and high 
composite SES) (Tables 3.3 and 3.4). Those of Other race reported the lowermost levels of some 
SES measures (i.e., less than high school education, annual household income below $25K, PIR 
< 1, low composite SES, and a healthcare cost barrier). Missing income was least common 
among White men, followed by Asian men. Among women, missing income was least frequent 
among NHOPI, but no different among Whites, Asians, and those of Other race.  
 Both current and lifetime asthma prevalence were independently associated with each of 
the seven different SES indicator variables (e.g., education less than college graduate, lower or 
missing household and individual income levels, PIR levels below two or missing, composite 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 3.3. United States, by Native Hawaiian/Other Pacific Islander (NHOPI) or 
Asian race – Sample sizes and socioeconomic weighted population characteristics 
- Behavioral Risk Factor Surveillance System, 2001-2010. 











Education: <High school  1,126 11.0 (9.5,12.7) 2,897 4.9 (4.5,5.4) 
Education: High school  8,302 59.8 (57.5,62.1) 22,805 33.7 (32.8,34.6) 
Education: College 3,011 29.2 (27.2,31.3) 31,376 61.4 (60.5,62.3) 
Household income:  Missing 1,617 12.9 (11.4,14.7) 8,581 13.0 (12.4,13.6) 
Household income: <$15K 1,380 9.8 (8.4,11.4) 3,849 7.9 (7.3,8.4) 
Household income: <$25K 2,102 15.2 (13.7,16.9) 6,025 9.7 (9.2,10.3) 
Household income: <$35K 1,511 11.9 (10.5,13.6) 5,283 7.8 (7.3,8.3) 
Household income: <$50K 1,904 14.0 (12.4,15.7) 7,464 11.8 (11.2,12.4) 
Household income: <$75K 1,753 13.8 (12.3,15.3) 8,628 14.5 (13.9,15.1) 
Household income: ≥$75K 2,208 22.4 (20.5,24.4) 17,567 35.4 (34.6,36.3) 
Individual income: Missing 1,628 13.0 (11.5,14.8) 8,633 13.1 (12.5,13.7) 
Individual income: <$5K 1,539 16.6 (14.8,18.6) 3,369 10.0 (9.4,10.7) 
Individual income: <$10K 2,222 18.3 (16.5,20.4) 6,164 12.3 (11.6,12.9) 
Individual income: <$15K 1,961 14.6 (13.0,16.2) 6,963 13.1 (12.4,13.7) 
Individual income: <$20K 1,791 15.9 (14.3,17.5) 10,331 21.3 (20.6,22.1) 
Individual income: <$35K 2,127 14.4 (13.0,16.0) 12,741 19.1 (18.5,19.8) 
Individual income: ≥$35K 1,207 7.2 (6.3,8.1) 9,196 11.1 (10.7,11.6) 
PIR: Missing 1,631 13.2 (11.6,15.0) 8,634 13.1 (12.5,13.7) 
PIR: <1 2,068 17.5 (15.7,19.5) 4,886 11.4 (10.7,12.0) 
PIR: <2 3,005 21.3 (19.4,23.3) 9,058 14.5 (13.9,15.2) 
PIR: <3 2,397 17.1 (15.4,18.9) 9,727 15.8 (15.2,16.5) 
PIR: >=3 3,374 30.9 (28.8,33.0) 25,092 45.2 (44.3,46.1) 
Composite SES: Missing 1,638 13.4 (11.8,15.1) 8,711 13.2 (12.6,13.8) 
Composite SES: Low 711 7.5 (6.1,9.0) 1,619 3.0 (2.7,3.4) 
Composite SES: Mid 7,939 58.4 (56.1,60.7) 23,459 38.7 (37.8,39.6) 
Composite SES: High 2,187 20.7 (19.0,22.5) 23,608 45.1 (44.2,46.0) 
Employment: Unemployed 1,557 14.9 (13.2,16.7) 3,782 8.2 (7.7,8.7) 
Employment: Other 3,129 21.0 (19.3,22.8) 17,073 25.5 (24.7,26.3) 
Employment: Employed 7,733 64.1 (61.9,66.3) 36,236 66.3 (65.5,67.2) 
Healthcare cost barrier: Yes 1,284 17.0 (15.1,19.1) 3,628 11.2 (10.5,12.0) 




Table 3.4. United States, by White or Other race – Sample sizes and socioeconomic 
weighted population characteristics - Behavioral Risk Factor Surveillance System, 
2001-2010. 











Education: <High school  220,447 10.0 (9.9,10.1) 85,676 20.1 (19.8,20.4) 
Education: High school  1,481,666 56.2 (56.1,56.3) 242,891 58.7 (58.3,59.0) 
Education: College 877,248 33.8 (33.7,33.9) 92,045 21.3 (21.0,21.5) 
Household income:  Missing 349,296 12.8 (12.7,12.9) 65,664 15.2 (14.9,15.4) 
Household income: <$15K 222,374 7.7 (7.6,7.8) 76,909 15.2 (15.0,15.4) 
Household income: <$25K 372,229 12.8 (12.7,12.9) 93,864 21.4 (21.1,21.6) 
Household income: <$35K 289,986 10.4 (10.3,10.5) 53,558 12.7 (12.5,13.0) 
Household income: <$50K 378,270 14.1 (14.0,14.1) 50,774 12.7 (12.5,12.9) 
Household income: <$75K 394,050 15.8 (15.7,15.9) 39,846 10.4 (10.2,10.6) 
Household income: ≥$75K 579,159 26.4 (26.3,26.5) 42,653 12.5 (12.3,12.7) 
Individual income: Missing 350,977 12.9 (12.8,13.0) 66,152 15.3 (15.0,15.5) 
Individual income: <$5K 101,296 7.5 (7.4,7.6) 60,719 19.2 (18.9,19.4) 
Individual income: <$10K 269,727 12.0 (11.9,12.1) 82,860 20.0 (19.7,20.3) 
Individual income: <$15K 328,427 13.6 (13.6,13.7) 57,187 13.9 (13.7,14.1) 
Individual income: <$20K 411,325 18.1 (18.1,18.2) 46,946 11.4 (11.2,11.6) 
Individual income: <$35K 663,871 22.6 (22.5,22.7) 69,096 13.7 (13.5,13.9) 
Individual income: ≥$35K 459,741 13.3 (13.2,13.3) 40,308 6.6 (6.5,6.7) 
PIR: Missing 350,982 12.9 (12.8,13.0) 66,159 15.3 (15.0,15.5) 
PIR: <1 183,536 9.2 (9.1,9.3) 86,372 22.0 (21.7,22.3) 
PIR: <2 438,137 16.7 (16.6,16.8) 104,275 24.3 (24.0,24.5) 
PIR: <3 479,590 17.2 (17.1,17.3) 65,079 14.8 (14.6,15.0) 
PIR: >=3 1,133,119 44.0 (43.9,44.2) 101,383 23.7 (23.4,23.9) 
Composite SES: Missing 352,604 12.9 (12.9,13.0) 66,833 15.4 (15.2,15.7) 
Composite SES: Low 120,078 6.0 (5.9,6.1) 55,046 13.3 (13.1,13.5) 
Composite SES: Mid 1,403,379 53.6 (53.5,53.8) 237,285 56.5 (56.2,56.8) 
Composite SES: High 709,303 27.4 (27.3,27.5) 64,104 14.8 (14.6,15.0) 
Employment: Unemployed 243,387 9.5 (9.4,9.6) 81,462 17.6 (17.3,17.8) 
Employment: Other 933,392 30.0 (29.9,30.1) 113,963 22.9 (22.7,23.2) 
Employment: Employed 1,400,807 60.5 (60.4,60.6) 224,860 59.5 (59.2,59.8) 
Healthcare cost barrier: Yes 206,648 12.3 (12.2,12.4) 65,836 21.8 (21.5,22.1) 
Healthcare cost barrier: No 1,793,108 87.7 (87.6,87.8) 260,584 78.2 (77.9,78.5) 
78 
Socioeconomic Associations with Asthma Prevalence By Sex and Race in 
the United States, After Control for Sociodemographics 
 When stratified by both sex and race, consistent inverse gradients between adjusted 
asthma prevalence and ordinal SES measures were demonstrated only among Whites and 
women of Other race, with few exceptions (Tables 3.5 thru 3.12). Specifically, there were 
significant linear trends of decreasing adjusted asthma prevalence from the lowest 
socioeconomic stratum to the highest among Whites (Tables 3.9 and 3.10) and those of Other 
race (Tables 3.11 and 3.12), except among Other race men reporting an asthma ever-diagnosis. 
For example, current asthma among White women was 80% more common among those in the 
lowest level of household income than in the highest, after controlling for sociodemographics. In 
addition, Whites and those of Other race reported asthma more often when also reporting 
unemployment or a healthcare cost barrier, compared to those employed or without a cost 
barrier, respectively. For instance, adjusted current asthma among White and Other race men 
was 2.1 times more common among the unemployed than the employed.  
 Among Whites and those of Other race, differences in asthma prevalence between low 
versus high measures of SES were often greater for current than for lifetime asthma (Tables 3.9 
thru 3.12). In addition, prevalence estimates meaningfully changed after controlling for other 
covariates only among Whites and Other race women. Specifically, multivariable adjustment 
increased comparative differences in asthma prevalence by SES level, except for unemployed 
versus employed White women. For example, crude current asthma prevalence among women 
of low compared to high composite SES was PR=1.4 (1.3,1.5), which changed to aPR=1.6 (1.5,1.7) 
after adjustment. Similarly, crude current asthma prevalence among men of lowest compared to 
highest household income was PR=1.8 (1.7,1.9), which changed to aPR=2.1 (1.9,2.2) after 
adjustment. 
 The magnitude of elevated within-race adjusted asthma prevalence among lower SES 
levels (compared to the uppermost level) was in some instances greater for Whites (Tables 3.9 
and 3.10) than for those of Other race (Tables 3.11 and 3.12). For example, lifetime asthma 
prevalence was elevated more for White than Other race women reporting the lowest levels of 
annual household or individual income, lower levels of PIR, low composite SES, unemployment, 
and having a healthcare cost barrier. Men of White race and PIR < 1 were 40% more likely to 
report lifetime asthma compared to those with PIR ≥ 3, whereas for men of Other race the 
adjusted association between PIR < 1 and lifetime asthma prevalence was less (aPR=1.1). 
Similarly, the magnitudes of the relationship between lower household income levels (categories 
less than $35K) and elevated asthma prevalence were also somewhat stronger for White than for 
Other race men. 
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 In contrast to lower SES, the degree to which within-race asthma prevalence was 
elevated among middle/upper socioeconomic levels (compared to the uppermost level) was 
often greater for those of Other race than for Whites (Tables 3.9 thru 3.12). For instance, for 
those of Other race a report of current asthma was 30% more frequent among mid-level 
composite SES than for high, whereas prevalence was only 10% more frequent for mid-SES 
Whites. Similarly, the magnitudes of adjusted prevalence ratios were greater for Other race men 
than for White men within the mid- and upper-level SES categories of having a high school 
education and annual individual income < $35K. 
 For NHOPI women, like White and Other race women, point estimates of adjusted 
asthma prevalence were elevated among those reporting the lowest levels of some SES measures 
compared to the highest, especially for current asthma, although these associations were 
significant only for employment and income (Table 3.5). For example, after controlling for 
covariates among NHOPI women, current asthma was 80% more prevalent among those with 
an unemployed status compared to employed and was nearly twice as likely at the lowest level of 
household income compared to the highest. Asthma prevalence was marginally higher for 
NHOPI having a cost barrier to healthcare compared to not having this healthcare barrier, 
including after adjustment for recent healthcare utilization. For NHOPI men, there was reduced 
power to detect differences in lifetime asthma prevalence for low versus high levels of SES, and 
prevalence could not be estimated for current asthma due to small sample sizes (Table 3.6). 
However, both crude and adjusted lifetime asthma prevalence were highest among NHOPI men 
at mid-levels of household income, while highest lifetime asthma prevalence estimates at mid-
levels of education and composite SES were marginally significant. Similarly, crude current 
asthma prevalence was highest among NHOPI men at mid-levels of education, individual 
income, and reporting an unemployed status. In contrast to men, NHOPI women had somewhat 
less asthma at middle levels of some SES indicators, with higher asthma burden at lowest and 
highest SES levels. For example, lifetime asthma was less common among NHOPI women at 
PIR < 2 than at the highest level of income. 
 Asians in middle levels of individual income and/or PIR also often had lower asthma 
prevalence estimates compared to those in lower or upper levels, although associations were not 
always significant (Tables 3.6 and 3.7). However, current asthma among Asians was elevated for 
unemployed compared to employed, and Asian women with a healthcare cost barrier had 




 Among race/sex groups not reporting household income, both lifetime and current 
asthma prevalence estimates were elevated compared to those reporting the highest income, 
except among Asian women. Asthma associations with missing income were especially 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Asthma Prevalence Disparities By Race in the United States, After Control 
for Socioeconomic Status and Sociodemographics 
 After controlling for covariates, and within subpopulations defined by different measures 
of SES, racial disparities in US asthma prevalence were attenuated but continued to persist in 
some strata for both women and men (Tables 3.13 thru 3.16). Regardless of sex/SES, asthma 
prevalence estimates were consistently and demonstrably lowest for Asians, including after 
adjustment. Estimates of racial disparities in asthma prevalence were meaningfully altered by 
adjustment for potential sociodemographic confounders only for Whites.  
 Adjusted asthma prevalence estimates were often highest for NHOPI compared to all 
other racial groups, although these results were not significant and depended on sex, SES 
measure, and asthma type. For example, point estimates of adjusted lifetime asthma prevalence 
among women reporting the lowest levels of each SES measure were consistently most elevated 
for NHOPI women (Table 3.13), and most elevated for NHOPI men who reported the lowest 
levels of income, PIR, unemployment, or having a healthcare cost barrier (Table 3.14). Within 
the upper levels of each SES measure, except education and composite SES, an asthma ever-
diagnosis was consistently most common among women identifying as NHOPI. Similarly, 
among men who reported college graduation, highest individual income, highest composite SES, 
employment, or no healthcare cost barrier, lifetime asthma was most common among NHOPI. 
Additionally, within both of the uppermost household and individual income levels as well as 
within some middle levels of SES measures such as education and mid composite SES, point 
estimates of lifetime asthma prevalence were most elevated by race for NHOPI. Racial 
disparities in lifetime asthma within middle levels of income or PIR < 2 were greatest for 
NHOPI men but not NHOPI women.   
 Among women who reported the same level of an SES indicator, adjusted current 
asthma prevalence was often somewhat higher among those of Other race than among NHOPI, 
although such inter-racial differences were not statistically significant. However, this pattern 
reversed within the lowest levels of some SES measures: Current asthma was somewhat more 
common among NHOPI than Other race women only for those reporting the lowest levels of 
income, PIR, composite SES, or unemployment.  
 Adjusted estimates of lifetime and current asthma prevalence were not demonstrably 
different among Whites and those of Other race, regardless of sex and SES. However, point 
estimates of asthma prevalence were often somewhat higher among Other race women than 
Whites, especially for current asthma.  
 For SES/sex groups not reporting household income, racial differences in asthma 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 This investigation found that during the decade between 2001-2010, racial disparities in 
asthma prevalence persisted among US NHOPI both after adjustment for sociodemographic 
characteristics and after controlling for SES using stratification with a variety of SES indicators 
including education, income, poverty status, education combined with income, employment 
status, and having a cost barrier to healthcare. That is, elevated asthma prevalence among 
NHOPI compared to Asians, Whites, and/or those of Other race was not sufficiently explained 
by differences in geographic region, time, sex, age, BMI, ever-smoking, healthcare access or 
utilization, nor by the measures of SES utilized by this study. Although not always as great as the 
excess burden of asthma among NHOPI, elevated asthma prevalence compared to Asians 
similarly persisted for Whites and those of Other race after statistical multivariable control for 
sociodemographics and direct control for SES via stratification.  
 However, this study also found that US asthma disparities by race were modified by level 
of SES, as well as by sex and/or type of SES measure. Most notably, for White and Other race 
men, the gap in lifetime asthma prevalence compared to Asians narrowed at lowermost levels of 
education, individual income, PIR, and composite SES; uniquely, asthma prevalence estimates 
compared to Asians were no longer demonstrably higher among Whites or Other race men 
within these lowermost SES categories. For NHOPI, asthma disparities for women were more 
pronounced at the lowest and highest levels of some SES measures, whereas the largest 
disparities for NHOPI men tended to occur at middle levels of some SES measures. When added 
to the adjustment models, sociodemographic characteristics such as healthcare coverage, access, 
and recent utilization did not change relationships between race and asthma within sex/SES 
groupings. 
 In addition, this investigation found that SES has had especially strong and consistent 
inverse associations with asthma prevalence for Whites. That is, asthma prevalence consistently 
declined with SES gains among Whites. However, while NHOPI women also exhibited worse 
asthma prevalence at lowest SES levels, these associations were not significant and some also 
trended toward more complex non-linear distributions between SES and asthma prevalence. 
NHOPI men either exhibited no differences in lifetime asthma prevalence between levels of SES 
(e.g., PIR, employed versus unemployed, and without versus with a healthcare cost barrier), or 
had somewhat worse prevalence at mid-levels of SES (e.g., education, household and individual 
income, and composite SES). Asian men who were unemployed and Asian women with a cost 
barrier to healthcare exhibited substantially worse asthma prevalence than their counterparts 
with better SES. Otherwise, relationships between asthma and SES among Asians were invariant 
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or prevalence trended higher at one or both ends of the SES spectrum. Like Whites, those of 
Other race nearly always reported asthma less often as SES increased, but to a lesser degree than 
did Whites; for Other race, differentials in asthma prevalence between lower/middle versus 
uppermost SES levels were often significant, but less than the gradient observed for Whites. 
These disparate associations between asthma and SES across sex/race subgroups were not 
meaningfully reduced by adjustment for other sociodemographic factors and were also 
congruent with observed racial differences in the asthma burden across sex/SES groupings. 
 In summary, during a past decade of the US asthma epidemic, poverty and/or at least 
one indicator of lowermost SES has been associated with asthma regardless of race. In some 
instances, the effect between lowest SES and elevated asthma prevalence was somewhat greater 
for one or more US racial minorities (e.g., NHOPI women and Asians), but in other instances 
the effect estimate was greater for Whites. In addition, relationships between lower SES and 
asthma did not demonstrate a threshold effect. Instead, incremental SES gain corresponded 
with improved asthma outcomes in a dose-response way invariably for Whites, as well as for 
those of Other race using most of the SES measures investigated. But unlike Whites, lesser 
burdens of asthma with gains in SES were not consistently experienced by those of Other race, 
nor for NHOPI or Asians. Instead, there were many instances in which adjusted asthma 
prevalence estimates for these population subgroups were elevated at middle, upper, or even 
uppermost levels of SES (depending on race, sex, SES measure type, and asthma type). Such 
patterns, in which health-SES associations are inequitable by race, have been previously 
observed for many health outcomes (62-65), including for asthma (19, 24, 46, 48).  
 In conclusion, the findings of this investigation suggest that nongenetic and modifiable 
SES/environmental factors play an important but complex role in US asthma prevalence 
disparities, including for NHOPI: Asthma prevalence increased over time and the ability of US 
Census racial categories to predict asthma prevalence was conditional on SES. This adds to a 
large body of literature demonstrating that single measures of SES as main effects, and/or uses 
of racial/ethnic categories without recognition of their basis and strong interactions with SES, 
may fail to sufficiently capture the complex and highly interactive societal factors involved in the 
differential patterns of preventable diseases observed in the US population by race. That is, this 
study’s findings are consistent with the conclusion that associations between asthma and race 
are residually confounded by insufficient measures of SES and/or inadequate models of the 
societal conditions that underlie, operationalize, and interact with racial categorizations; racial 
differences in SES are not fully captured by typical measures of SES. Additional and more 
sophisticated systems-level inquiries are instead needed to explain population-level differences 
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in the incidence and duration of asthma, including among US residents who are well above the 
poverty line. Rather than reification of race, monitoring social drivers of health aligned with 
race, combined with investigating effect modifications from many combinations of multiple 
factors, should enable more effective public health interventions for the elimination of health 
inequities. 
 The limitations of this investigation that involve reduced statistical power due to modest 
sample sizes in some strata, bias from race misclassification, and the self-reported nature of the 
BRFSS data, have been previously described in studies 1 and 2. Additional limitations include: 1) 
The utilized asthma outcome measures themselves depend on healthcare usage and/or quality. 
Such information bias introduces uncertainty regarding how much the observed patterns in 
prevalence reflect healthcare-related factors rather than the health outcome of interest. 
However, differences in healthcare along race/SES lines may be an even more important health 
inequity to document and redress; 2) The interpretation of this study’s cross-sectional 
associations with adult prevalence can be problematic. First, it cannot be determined from these 
data whether reduced SES causes asthma, or whether poor health with a chronic and potentially 
debilitating condition such as asthma reduces socioeconomic conditions. However, associations 
between health outcomes and SES represent public health inequities regardless of the nature or 
direction of the causes, especially if such associations depend upon the socio-political construct 
of race. Second, the prevalence metric comprises an interaction between incidence and duration 
while lacking any information about time; morbidity at middle or older ages cannot be 
compared among groups if those groups experience different rates of survival or successful 
disease treatment. This limitation is particularly relevant to current asthma, which can be much 
reduced with sustained treatment and healthcare-based management. Also, SES and its health 
impacts are both dynamic and accrue across the lifespan, which limits the utility of measures 
made at only a single point in time. These limitations that are related to the cross-sectional 
nature of this investigation could be remedied with measures of asthma incidence instead of 
prevalence, and with SES measures at different times in the life cycle. However, such resource-
intensive approaches are often not practical, necessitating studies such as this one that attempt 
to glean inferences from available data; 3) Asthma defies easy diagnosis or definition because 
similar symptoms occur along a spectrum of severity and reflect respiratory disorders of 
differing, interacting, and often unknown etiologies (1-3, 99). These different disease entities 
likely differ in their associations with SES and race, and indeed opposite relationships between 
SES and atopic versus nonatopic asthma have been shown (99). This investigation could 
therefore be strengthened by the incorporation of additional information that would help to 
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distinguish asthma phenotypes (e.g., comorbidities such as allergic conditions). 4) This 
investigation’s analyses used the missing-indicator method in which missing income was treated 
as a separate category of income response. While this method is popular and maximizes sample 
size, it may also bias estimates (100). Alternative methodologies include complete case analysis 
or multiple imputation, but these may also bias estimates. To improve this investigation with 
estimates of bias direction and magnitude, results should be generated and compared using all 
three missing data approaches. 
 Despite these limitations, this study contributes one of the few studies of asthma racial 
disparities to take into account both SES and its interactions with race, and the only study to do 
so for any chronic disease with excess impacts on US NHOPI. There have long been calls for 
such disaggregation of data on NHOPI from Asian populations (77, 78), which is now made 
possible by the consistent nationwide and multi-year BRFSS resource that implemented this 
mandate. Finally, this study is also strengthened by use of multiple SES measure types, each of 
which likely reflect different points along a complex and continuous spectrum of a variety of life 
course exposures. 
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STUDY 4: DOMINANT PREDICTORS OF ADULT ASTHMA PREVALENCE VARY BY 
SEX, RACE, AND SOCIOECONOMIC STATUS IN THE UNITED STATES 
INTRODUCTION 
 As demonstrated in studies 1 thru 3, to affect national-level progress toward asthma 
reduction and related health equity goals successes are needed broadly and across all levels of 
SES. However, there is also urgent need for prevention of asthma especially among the socially 
disadvantaged, including some racial/ethnic minorities such as NHOPI who have particularly 
grievous yet preventable disease burdens and mortality (26, 34, 36, 53, 54, 57, 58).  
 Myriad asthma associations and their relative strengths have been well-documented, 
with many well-established risk factors known (e.g., female sex, young age, obesity, smoking, 
and aspects of healthcare), but with many associations less well-understood (e.g., time periods, 
western and northeastern US regions, race/ethnicity, and lower SES) (5-8, 12, 13, 18-24, 30, 52). 
Multivariable regression models are frequently used to determine the relative strengths of these 
asthma associations, as well as the magnitude of excess asthma among different subpopulations, 
while controlling for potential confounders. Prevention programs often target the strongest risk 
factors and/or the subpopulations that exhibit the most elevated adjusted asthma prevalence. 
  However, a factor’s comparative strength of association from a multiple regression 
analysis does not necessarily reflect its ability to predict asthma, because factors are often highly 
correlated. That is, model coefficients are context-dependent and change depending on other 
included covariates. Indeed, a covariate can exhibit little or no association with the modelled 
outcome but can yet be a very good predictor of the outcome. Therefore, ranked magnitudes of 
adjusted odds or prevalence ratios derived from regression coefficients are not indicators of 
relative importance, when ‘importance’ refers to predictive ability (i.e., the amount of outcome 
variance explained) – although such estimates and/or their p-values may be both misleadingly 
and commonly portrayed as indicative of effect ‘importance’ in the epidemiologic literature.  
 Instead, covariate ‘importance’ may be derived from predictive ability in a multivariable 
regression model and all subsets of that model, as measured by model goodness-of-fit. Such a 
definition of importance will account for collinearity that frequently exists between factors. 
Rooted in decision theory, dominance analysis provides both a straightforward method and 
summary statistics for evaluating covariate importance. Dominance analysis is also a highly 
recommended but often neglected adjunct to traditional multiple regression analyses (101-105).  
 The distinction between covariate association strength versus explanatory importance is 
highly relevant for applied epidemiologic research because programs aimed at reducing asthma 
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may benefit not only from targeting specific subpopulations with high prevalence, but also from 
prioritizing the most influential asthma risk factors within those groups. However, the 
comparative explanatory importance of factors involved in US racial and/or SES disparities in 
asthma has not yet been investigated using dominance analysis.  
 With particular interest in the substantial racial and SES disparities in asthma among 
NHOPI, Whites, and Asians in the US (12, 26, 53, 54), this investigation asked: ‘Given the 
existence of many asthma risk factors, combined with their interconnected relationships both 
within and across subpopulations defined by sex, race, and/or SES – which asthma predictors 
are the most important for different sex/race or sex/SES groups?; do these factors have the 
same relative predictive ability for asthma among different races?; do these factors make the 
same relative explanatory contributions to the prediction of asthma among different levels of 
SES?’  
 Specifically, with data from a large and nationally-representative US health survey, the 
aims of this investigation were to: 1) Review sociodemographic associations with asthma 
observed in this dataset, for US race subpopulations comprised of NHOPI, White, Asian, or 
Other races, by sex, after adjustment for sociodemographic and SES characteristics; 2) similarly 
quantify and summarize adjusted sociodemographic and racial asthma associations, for 
subpopulations defined by level of SES and sex; 3) determine which factors are the most 
important in predicting asthma within each of these racial and SES subpopulations, using 
dominance analysis; 4) compare the relative importance of dominant asthma predictors to their 
relative strengths of association with asthma.  
METHODS 
 The complete details of the utilized BRFSS national health survey for 2001-2010, 
including the asthma outcomes, race definitions, and sociodemographic covariates predictive of 
asthma prevalence were the same as described for studies 1 and 3. The SES-representative 
categorical variable of education attainment (i.e., less than a high school diploma, high school 
graduation, or college graduation) was selected for this analysis because it is one of the most 
widely used SES indicators and may be less affected by the asthma outcomes themselves (97). In 
contrast to study 3, the asthma prevalence adjustment model utilized in this study included only 
main effects, due to the inability of dominance analysis to include model interaction terms; 
inclusion of interaction terms for US region and race did not meaningfully alter the strengths of 
most asthma associations within groupings by sex/race or sex/education (data not shown). 
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 To determine whether a covariate’s relative ability to explain elevated asthma prevalence 
varied by race, dominance analyses were conducted within all sex/race subpopulations, for 
lifetime and current asthma. Similarly, to investigate whether the SES indicator of education 
attainment modified the relative importance of the other sociodemographic asthma prevalence 
predictors (including race), dominance analyses were conducted within all sex/education 
subpopulations.  
 Dominance Analysis Definitions and Methodology 
 Dominance analysis quantifies and compares the contribution of each covariate to the 
chosen model, for all submodels; it thereby accounts for each covariate’s ability to predict the 
outcome directly, as well as conditionally on all subsets of the other covariates (101-104). To 
investigate the relative predictive importance among the correlated covariates of this study’s 
selected logistic regression model of asthma prevalence, dominance analyses were conducted 
using the procedure described by Azen and Traxel, 2009 (102, 104). Specifically, the 255 unique 
submodels possible for this study’s eight covariates (i.e., region, time period, age, BMI, smoking, 
healthcare coverage, healthcare provider, and either race or education attainment) were fit to 
each outcome (lifetime or current asthma). For each outcome, this involved eight base 
submodels (k=1, s1=8; k=2, s2=28; k=3, s3=56; k=4, s4=70; k=5, s5=56; k=6, s6=28; k=7, s7=8; 
k=8, s8=1), where k is the number of included covariates in the base submodel, and sk is the 
number of unique submodels of size k (Appendix Table 5.16 describes the analysis plan, after 
Table 2 in Azen & Traxel (2009)).  
 Goodness of logistic regression model fit was quantified using the analogue R2 of 
McFadden that is based on the likelihood ratio (104, 106). The additional contribution that a 
covariate makes to the fit of a base submodel was quantified using the difference in McFadden 
R2 between the submodel with the covariate versus without. Larger differences in the McFadden 
R2 indicated greater improvement in model predictive ability. The relative importance of each of 
the eight covariates was then ranked according to the amount by which it improved the 
predictive ability of each of the base submodels; a covariate that consistently explained more 




 The eight covariates were also ranked at each of the eight k-levels according to the mean 
amount the covariate contributed to submodel fits (Mik); a covariate (i) was ‘conditionally 
dominant’ over another (j) if its average explanatory rank was greater at every k-level (i.e.,  
Mik > Mjk). Additionally, each covariate was assessed for ‘general dominance’ using the overall 
average of its k-level mean contributions to submodel fit: 
Di = (∑Mik)/8 
 To assess the magnitude of general dominance of one covariate (i) over another (j), the 
difference was taken between each covariate’s overall average k-level mean predictive 
contribution: 
Gij = Di - Dj 
General dominance was considered meaningful when Gij ≥ 0.01; Azen & Traxel (2009) 
demonstrated that this magnitude of Gij yielded general dominance reproducibility of more than 
70%, using bootstrap of data from a small self-report health survey (102, 104). Statistical 
significance for general dominance was set at Gij ≥ 0.02, which yielded reproducibility values 
greater than 95% in the Azen & Traxel (2009) empirical investigation (104).  
 Lastly, using the relationship that the sum of the overall averages of all covariate k-level 
mean contributions to submodel fits is equal to the full model’s McFadden R2,  
R2full model = ∑Di 
the summary magnitude of the predictive contribution of each covariate in the final model was 
additionally quantified as a percentage of the final model’s fit. 
RESULTS 
United States Sample and Population Characteristics By Sex and Race, and 
By Sex and Socioeconomic Status 
 Descriptive statistics for the 2001-2010 BRFSS dataset for US overall, which comprised 
over 3 million records, were described in studies 1 and 3.  
 There were substantial socioeconomic differences by race (Appendix Tables 5.11 thru 
5.15). In addition, differences among the three subpopulations defined by education attainment 
were also numerous for characteristics relevant to asthma (data not shown). For example, young 
(18-34 years) females were more likely to be college graduates compared to males, while older 
(≥ 65 years) females were more likely to have less than a high school degree. However, at middle 
age there were only small differences in education attainment between sexes. Obesity was most 
prevalent among those who reported the lowest level of education and especially so for females, 
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while college graduate males reported overweight more often than males reporting less 
education. Having ever smoked declined consistently with education attainment among males, 
whereas high school graduate females reported ever-smoking more often than females not 
having a high school degree. However, college graduate females were less likely to be ever-
smokers than college graduate males. Proportions of those having either healthcare coverage or 
provider increased in a dose-response manner with education level. 
Relative Strengths of Associations with Asthma Prevalence in the United 
States, By Sex and Race 
 The magnitudes of observed crude and adjusted associations between asthma prevalence 
and racial, sociodemographic, and SES characteristics within this national dataset, both overall 
and within subgroups defined by sex and race, were presented in studies 1 and 3. In study 3, 
adjustment of asthma prevalence estimates included both main and interaction effects for 
education attainment, as well as for other sociodemographic characteristics including region. In 
this investigation, adjustment of asthma prevalence estimates included only main effects. 
However, these differences in predictive models did not meaningfully alter previous findings 
regarding racial asthma disparities and racial differences in sociodemographic asthma 
associations (Tables 4.1 thru 4.4). In review: Race modified associations between asthma and a 
variety of SES indicators, with only Whites and women of Other race experiencing consistent 
gradients of declining asthma prevalence between the lower- and upper-most levels of SES, 
including after adjustment for potential confounders. For the SES measure of education, 
estimates of asthma prevalence were lowest among those with the highest education attainment, 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Dominant Asthma Predictors in the United States, By Sex and Race 
 The relative abilities of covariates to explain asthma prevalence varied by both sex and 
race (Tables 4.5 and 4.6). BMI was the most important predictor of both lifetime and current 
asthma among White and Other race females (on average explaining 54% of the variance in 
current asthma among Whites, and 35% of current asthma among Other race). BMI also had the 
greatest predictive ability for current asthma among Asians of both sexes (substantially 
explaining 51% for females, 43% for males), and had secondary general dominance for lifetime 
asthma. Moreover, among White and Other race females, and all Asians with current asthma, 
BMI made the greatest average explanatory contribution in every set of submodels of the same 
size (i.e., BMI was conditionally dominant). BMI also ranked as the second-most important 
predictor of lifetime asthma for NHOPI males and ranked as the third-most important covariate 
among NHOPI females for both lifetime and current asthma.  
 Unlike White and Other race females, the most important predictors of asthma among 
NHOPI females were ever-smoking and US region; as a predictive covariate of current asthma, 
region was completely dominant (i.e., region made the greatest predictive contribution in all 
submodels), and also had the strongest adjusted prevalence ratio estimates (Tables 4.5 and 4.6). 
Among Asian females, region was also the best on-average predictor of ever-diagnosis with 
asthma. Having ever smoked was the second most important predictor of asthma among Other 
race females.  
 For males of White, Asian, and Other race, age was the most important explanatory 
factor of lifetime asthma, being completely dominant and predicting more for Whites (56%) and 
Other race (48%) than for Asians (29%) (Tables 4.5 and 4.6). For current asthma, no one 
covariate was meaningfully more predictive among White males, while having a healthcare 
provider was a conditionally dominant covariate among Other race males. Uniquely, the time 
period of the survey best explained lifetime asthma prevalence among NHOPI males. Also, the 
SES indicator of education attainment was uniquely and generally dominant (explaining 20% of 
lifetime asthma) among male NHOPI.  
 In sex/race subpopulations, the relative importance of BMI from dominance analyses 
was congruent with its relative rank in strengths of association with asthma prevalence. 
Otherwise, dominance analyses augmented the multivariable regression results by enabling 
distinctions in asthma predictive ability between covariates with similar asthma association 
strengths. For example, adjusted lifetime asthma prevalence ratios for ever-smoking and 
healthcare coverage were similar among NHOPI females (both with aPR=1.5), but dominance 
analysis indicated that ever-smoking played a more influential role in predicting an asthma 
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ever-diagnosis than did healthcare coverage in this subgroup. For NHOPI males, dominance 
analysis distinguished education attainment as a more important predictor of lifetime asthma 
than ever-smoking, or residence in Hawai‘i or western states (all with aPR=1.4). For Asian 
males, age was a greater contributor to the model than obesity (aPR=2.0) or residence in 
Hawai‘i (aPR=1.8), despite a much weaker associations between age and lifetime asthma. 
Table 4.5. United States, women by race - Dominant predictors of asthma 
prevalence - Behavioral Risk Factor Surveillance System, 2001-2010. 




Dominant Covariates & Percent of Asthma Explained 
 NHOPI Asian White Other Race 
1st Smoking 31% Region 25% BMIb 47% BMIb 33% 
2nd Region 26% BMI 25% None NA Smokingb 24% 
3rd BMIb 19% None NA None NA None NA 
 Current asthma 
Dominant Covariates & Percent of Asthma Explained 
 NHOPI Asian White Other Race 
1st Regiona 36% BMIb 51% BMIb 54% BMIb 35% 
2nd Smoking 20% None NA None NA Smokingb 23% 
3rd BMI 20% None NA None NA None NA 
a: Completely dominant; b: Conditionally dominant 
Table 4.6. United States, men by race - Dominant predictors of asthma prevalence - 
Behavioral Risk Factor Surveillance System, 2001-2010. 




Dominant Covariates & Percent of Asthma Explained 
 NHOPI Asian White Other Race 
1st Time period 23% Age 29% Age
a 56% Agea 48% 
2nd BMI 23% BMI 28% None NA None NA 
3rd Education 20% None NA None NA None NA 
 Current asthma 
Dominant Covariates & Percent of Asthma Explained 
 NHOPI Asian White Other Race 
1st NA NA BMIb 43% None NA Healthcare providerb 38% 
2nd NA NA None NA None NA None NA 
3rd NA NA None NA None NA None NA 
a: Completely dominant; b: Conditionally dominant 
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Relative Strengths of Associations with Asthma Prevalence in the United 
States, By Sex and SES 
 Among subpopulations defined by sex and level of SES as indicated by one of three 
different levels of education attainment, elevated asthma prevalence as compared to Asians was 
found in study 3 to persist among NHOPI, Whites, and those of Other race, including after 
multivariable adjustment, except among males who reported the lowest level of education. In 
addition, there was a notable racial disparity in adjusted lifetime asthma among high school 
graduate males, with NHOPI males not only reporting asthma ever-diagnoses more frequently 
than Asians, but also more frequently than White or Other race (Tables 4.7 thru 4.10).  
 Adjusted asthma prevalence increased with time only for males, and marginally 
increased with time more so for those without a college degree (Tables 4.7 thru 4.10). Asthma 
associations with younger age were modified by sex, but not by SES as indicated by education 
attainment. Associations between adjusted asthma prevalence and the risk factors of obesity and 
ever-smoking were strongest for females regardless of education level. However, as education 
level increased the strength of asthma associations with obesity also marginally increased. In 
contrast, asthma associations with ever-smoking markedly decreased with greater education 
attainment; ever-smoking was strongly associated with asthma prevalence within the lowest 
level of education but was not associated within the highest education level. Having healthcare 
coverage predicted asthma only among those with less than a high school education, with 
stronger associations among females. Having a healthcare provider was most strongly 
associated with asthma prevalence among those without a high school degree, with stronger 
associations among males. 
 Also among sex/education strata, this investigation found that the largest geographic 
differences in asthma prevalence were between Hawai‘i and the South, and between the western 
region as compared to the South, with adjusted asthma prevalence highest among high school 
and college graduate females who resided in Hawai‘i (Tables 4.7 thru 4.10). Moreover, the 
degree to which asthma was elevated in Hawai‘i marginally increased with education level 
regardless of sex. However, those with the least education reported asthma less often in the 
West than in the South after adjusting for potential confounders, especially among males. 
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Table 4.7. United States, women by education attainment – Lifetime asthma 
associations, adjusted for race and sociodemographic characteristics - Behavioral 
Risk Factor Surveillance System, 2001-2010. 
United States Women – Lifetime asthma 
















Race: NHOPI 1.9 (1.1,3.2) 1.6 (1.3,2.0) 1.7 (1.3,2.3) 
Race: White 1.5 (1.0,2.1) 1.4 (1.2,1.7) 1.6 (1.4,1.7) 
Race: Other 1.5 (1.1,2.2) 1.6 (1.4,1.8) 1.6 (1.4,1.8) 
Race: Asian 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Region: Hawai‘i 1.1 (0.9,1.4) 1.5 (1.4,1.6) 1.5 (1.4,1.7) 
Region: West 0.9 (0.8,1.0) 1.3 (1.2,1.3) 1.3 (1.3,1.4) 
Region: Midwest 1.0 (1.0,1.1) 1.1 (1.0,1.1) 1.0 (1.0,1.1) 
Region: Northeast 1.1 (1.0,1.2) 1.1 (1.1,1.2) 1.2 (1.1,1.2) 
Region: South 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Time period: 2008-2010 1.0 (1.0,1.1) 1.1 (1.1,1.1) 1.0 (1.0,1.1) 
Time period: 2005-2007 1.0 (1.0,1.1) 1.0 (1.0,1.1) 1.0 (1.0,1.1) 
Time period: 2001-2003 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Age: 18-34 years 1.4 (1.3,1.5) 1.6 (1.5,1.6) 1.4 (1.4,1.5) 
Age: 35-64 years 1.3 (1.2,1.4) 1.3 (1.2,1.3) 1.2 (1.1,1.2) 
Age: >=65 years 1.0 (ref) 1.0 (ref) 1.0 (ref) 
BMI: Obese 1.5 (1.4,1.6) 1.6 (1.6,1.7) 1.7 (1.6,1.7) 
BMI: Overweight 1.1 (1.0,1.1) 1.1 (1.1,1.2) 1.3 (1.2,1.3) 
BMI: Not OW/OB 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Smoke: Ever 1.9 (1.8,2.0) 1.3 (1.3,1.3) 1.1 (1.1,1.1) 
Smoke: Never 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Healthcare coverage: Yes 1.3 (1.3,1.4) 1.0 (1.0,1.0) 0.9 (0.9,1.0) 
Healthcare coverage: No 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Healthcare provider: Yes 1.5 (1.3,1.6) 1.2 (1.2,1.3) 1.3 (1.2,1.3) 
Healthcare provider: No 1.0 (ref) 1.0 (ref) 1.0 (ref) 
aAdjusted for: Region, time period, age, BMI, smoking, healthcare coverage, 




Table 4.8. United States, men by education attainment – Lifetime asthma 
associations, adjusted for race and sociodemographic characteristics - Behavioral 
Risk Factor Surveillance System, 2001-2010. 
United States Men – Lifetime asthma 
















Race: NHOPI 1.1 (0.5,2.4) 1.8 (1.4,2.4) 1.5 (1.1,2.1) 
Race: White 1.1 (0.7,1.9) 1.3 (1.1,1.5) 1.5 (1.3,1.6) 
Race: Other 1.1 (0.6,1.8) 1.4 (1.2,1.7) 1.5 (1.3,1.7) 
Race: Asian 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Region: Hawai‘i 1.1 (0.8,1.5) 1.3 (1.2,1.5) 1.4 (1.3,1.6) 
Region: West 0.7 (0.6,0.8) 1.2 (1.1,1.2) 1.3 (1.3,1.4) 
Region: Midwest 1.1 (1.0,1.2) 1.0 (1.0,1.1) 1.0 (1.0,1.1) 
Region: Northeast 1.0 (0.9,1.1) 1.1 (1.0,1.1) 1.1 (1.1,1.2) 
Region: South 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Time period: 2008-2010 1.2 (1.1,1.3) 1.2 (1.1,1.2) 1.1 (1.1,1.2) 
Time period: 2005-2007 1.2 (1.1,1.3) 1.1 (1.0,1.1) 1.1 (1.0,1.2) 
Time period: 2001-2003 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Age: 18-34 years 1.8 (1.6,1.9) 1.9 (1.8,2.0) 1.6 (1.5,1.7) 
Age: 35-64 years 1.2 (1.1,1.3) 1.2 (1.1,1.2) 1.1 (1.1,1.2) 
Age: >=65 years 1.0 (ref) 1.0 (ref) 1.0 (ref) 
BMI: Obese 1.2 (1.1,1.3) 1.2 (1.2,1.3) 1.3 (1.2,1.4) 
BMI: Overweight 0.8 (0.8,0.9) 0.9 (0.9,1.0) 1.0 (1.0,1.1) 
BMI: Not OW/OB 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Smoke: Ever 1.4 (1.3,1.5) 1.1 (1.1,1.2) 1.0 (1.0,1.1) 
Smoke: Never 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Healthcare coverage: Yes 1.2 (1.1,1.3) 1 (0.9,1.0) 1.0 (0.9,1.1) 
Healthcare coverage: No 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Healthcare provider: Yes 1.5 (1.4,1.7) 1.3 (1.3,1.4) 1.3 (1.3,1.4) 
Healthcare provider: No 1.0 (ref) 1.0 (ref) 1.0 (ref) 
aAdjusted for: Region, time period, age, BMI, smoking, healthcare coverage, 




Table 4.9. United States, women by education attainment – Current asthma 
associations, adjusted for race and sociodemographic characteristics - Behavioral 
Risk Factor Surveillance System, 2001-2010. 
United States Women – Current asthma 
















Race: NHOPI 2.0 (1.1,3.9) 1.8 (1.4,2.3) 1.7 (1.2,2.5) 
Race: White 1.8 (1.2,2.5) 1.7 (1.4,2.0) 1.8 (1.6,2.1) 
Race: Other 1.8 (1.3,2.6) 1.9 (1.6,2.3) 1.9 (1.6,2.2) 
Race: Asian 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Region: Hawai‘i 1.0 (0.8,1.4) 1.4 (1.3,1.5) 1.6 (1.5,1.8) 
Region: West 0.8 (0.7,0.9) 1.2 (1.2,1.3) 1.3 (1.3,1.4) 
Region: Midwest 1.0 (1.0,1.1) 1.1 (1.1,1.2) 1.1 (1.1,1.1) 
Region: Northeast 1.1 (1.0,1.2) 1.2 (1.2,1.2) 1.2 (1.2,1.3) 
Region: South 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Time period: 2008-2010 1.1 (1.0,1.1) 1.1 (1.0,1.1) 1.0 (1.0,1.0) 
Time period: 2005-2007 1.0 (0.9,1.1) 1.0 (1.0,1.1) 1.0 (0.9,1.0) 
Time period: 2001-2003 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Age: 18-34 years 1.3 (1.2,1.4) 1.5 (1.4,1.5) 1.3 (1.3,1.4) 
Age: 35-64 years 1.4 (1.3,1.5) 1.3 (1.2,1.3) 1.2 (1.1,1.2) 
Age: >=65 years 1.0 (ref) 1.0 (ref) 1.0 (ref) 
BMI: Obese 1.6 (1.5,1.7) 1.8 (1.8,1.9) 1.9 (1.8,2.0) 
BMI: Overweight 1.1 (1.0,1.1) 1.2 (1.1,1.2) 1.3 (1.3,1.4) 
BMI: Not OW/OB 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Smoke: Ever 2.0 (1.9,2.1) 1.4 (1.3,1.4) 1.1 (1.0,1.1) 
Smoke: Never 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Healthcare coverage: Yes 1.4 (1.3,1.5) 1 (1.0,1.1) 1 (0.9,1.0) 
Healthcare coverage: No 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Healthcare provider: Yes 1.6 (1.4,1.7) 1.4 (1.3,1.4) 1.4 (1.3,1.5) 
Healthcare provider: No 1.0 (ref) 1.0 (ref) 1.0 (ref) 
aAdjusted for: Region, time period, age, BMI, smoking, healthcare coverage, 




Table 4.10. United States, men by education attainment – Current asthma 
associations, adjusted for race and sociodemographic characteristics - Behavioral 
Risk Factor Surveillance System, 2001-2010. 
United States Men – Current asthma 
















Race: NHOPI 1.4 (0.6,3.5) 1.8 (1.3,2.6) 1.3 (0.8,2.2) 
Race: White 1.5 (0.9,2.6) 1.6 (1.3,2.1) 1.5 (1.3,1.8) 
Race: Other 1.5 (0.9,2.5) 1.8 (1.4,2.3) 1.5 (1.2,1.7) 
Race: Asian 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Region: Hawai‘i 1.0 (0.7,1.5) 1.3 (1.1,1.5) 1.2 (1.1,1.4) 
Region: West 0.6 (0.5,0.7) 1.2 (1.2,1.3) 1.4 (1.3,1.5) 
Region: Midwest 1.2 (1.1,1.3) 1.1 (1.1,1.2) 1.2 (1.1,1.3) 
Region: Northeast 1.1 (1.0,1.2) 1.2 (1.1,1.2) 1.3 (1.2,1.4) 
Region: South 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Time period: 2008-2010 1.2 (1.1,1.4) 1.2 (1.1,1.2) 1.1 (1.0,1.2) 
Time period: 2005-2007 1.1 (1.0,1.2) 1.1 (1.0,1.1) 1.1 (1.0,1.1) 
Time period: 2001-2003 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Age: 18-34 years 1.3 (1.2,1.5) 1.4 (1.3,1.5) 1.4 (1.3,1.5) 
Age: 35-64 years 1.1 (1.0,1.2) 1.0 (0.9,1.0) 1.1 (1.0,1.1) 
Age: >=65 years 1.0 (ref) 1.0 (ref) 1.0 (ref) 
BMI: Obese 1.2 (1.1,1.4) 1.3 (1.2,1.3) 1.4 (1.3,1.5) 
BMI: Overweight 0.8 (0.7,0.9) 0.9 (0.8,0.9) 1.0 (1.0,1.1) 
BMI: Not OW/OB 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Smoke: Ever 1.5 (1.4,1.7) 1.2 (1.1,1.2) 1.0 (1.0,1.1) 
Smoke: Never 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Healthcare coverage: Yes 1.2 (1.1,1.3) 0.9 (0.9,1.0) 1 (0.9,1.1) 
Healthcare coverage: No 1.0 (ref) 1.0 (ref) 1.0 (ref) 
Healthcare provider: Yes 1.9 (1.7,2.2) 1.6 (1.5,1.7) 1.6 (1.5,1.8) 
Healthcare provider: No 1.0 (ref) 1.0 (ref) 1.0 (ref) 
aAdjusted for: Region, time period, age, BMI, smoking, healthcare coverage, healthcare 
provider, and race. 
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 Dominant Asthma Predictors in the United States, By Sex and SES 
 The dominant predictors of adult asthma prevalence varied by SES as indicated by 
education attainment (Tables 4.11 and 4.12). Moreover, the comparative importance of asthma 
predictors was not congruent with rank according to magnitudes of association with asthma. In 
particular, race was not an important explanatory factor for asthma prevalence at any level of 
SES, despite very elevated adjusted asthma prevalence among NHOPI, Whites, and Other race 
as compared to Asians.  
 Instead of race, smoking status was the most important predictor of asthma prevalence 
for females reporting the lowest level of education attainment; ever-smoking contributed about 
half of the model’s predictive ability (52% for lifetime, 47% for current asthma) (Tables 4.11 and 
4.12). Moreover, ever-smoking was conditionally dominant over all other covariates, and 
primary general dominance of smoking was significant. Among those reporting the lowest level 
of education, possession of a healthcare provider ranked second in importance for females but 
ranked first for males (accounting for 26% of lifetime and 39% of current asthma variances 
among males). BMI was also among the most predictive covariates of current asthma for 
females with lowermost education. But in contrast for females, neither ever-smoking nor BMI 
were dominant covariates for males of lowest SES. Instead and despite weak associations with 
asthma, region ranked second in general dominance for both lifetime and current asthma 
among males who reported lowermost education. Age was the third most important predictor of 
lifetime asthma among males of lowest SES, despite having the strongest asthma association. 
 For females reporting the middle and highest levels of education attainment, ever-
smoking was not a meaningfully important asthma predictor (Tables 4.11 and 4.12). Instead, 
BMI was the sole most important and conditionally dominant covariate, significantly explaining 
more than half of the variance for current asthma (e.g., 52% for high school graduates and 60% 
for college graduates). Among high school graduate males, age was completely dominant, 
contributing 61% of the model’s predictive ability for lifetime asthma. No covariates were 
meaningfully dominant for high school graduate males reporting current asthma, or among 
college graduate males.  
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Table 4.11. United States, women by education attainment - Dominant predictors 
of asthma prevalence - Behavioral Risk Factor Surveillance System, 2001-2010. 




Dominant Covariates & Percent of Asthma Explained 
 < High school High school graduate College graduate 
1st Smokingb 52% BMIb 45% BMIb 53% 
2nd Healthcare providerb 15% None NA None NA 
3rd None NA None NA None NA 
 Current asthma 
Dominant Covariates & Percent of Asthma Explained 
 < High school High school graduate College graduate 
1st Smokingb 47% BMIb 52% BMIb 60% 
2nd Healthcare providerb 15% None NA None NA 
3rd BMI 11% None NA None NA 
a: Completely dominant; b: Conditionally dominant 
Table 4.12. United States, men by education attainment - Dominant predictors of 
asthma prevalence - Behavioral Risk Factor Surveillance System, 2001-2010. 




Dominant Covariates & Percent of Asthma Explained 
 < High school High school graduate College graduate 
1st Healthcare provider 26% Age
a 61% None NA 
2nd Region 22% None NA None NA 
3rd Ageb 19% None NA None NA 
 Current asthma 
Dominant Covariates & Percent of Asthma Explained 
 < High school High school graduate College graduate 
1st Healthcare providerb 39% None NA None NA 
2nd Regionb 26% None NA None NA 
3rd None NA None NA None NA 




 This investigation quantified and compared both the strengths of associations and the 
relative importance of several predictors of asthma prevalence, using multiple logistic regression 
with a multi-year and nationally representative sample of US adults classified by sex and race, as 
well as by groupings according to sex and SES as indicated by education attainment. Relative 
importance was defined and evaluated using a dominance analysis framework, which utilizes 
pairwise comparisons of the contributions of all model predictors to regression model fit (101-
104).   
 This method for assessing covariate importance encompasses all contexts of a covariate’s 
ability to explain the modelled outcome, by together considering direct, total, and partial effects. 
As such, the relative importance of a factor predictive of asthma, defined as the amount of 
asthma variance explained, may be distinct from the covariate’s comparative strength of 
association (which alone can be uninformative of importance, especially in the presence of 
multicollinearity). Dominance analysis thereby contributes additional information useful for 
decision-making: Prevention programs may benefit from prioritizing the most influential 
predictors, particularly when factor importance varies among the populations targeted for 
having higher asthma burdens (e.g., those of lower SES and/or certain ethnic/racial groups).  
 For modifiable lifestyle-related asthma risk factors with similar strengths of association 
within racial subgroups, dominance analyses indicated that ever-smoking was somewhat more 
important than BMI among NHOPI women, whereas BMI was more important than smoking 
for women of White, Asian, or Other race. BMI was also a dominant asthma predictor for 
NHOPI and Asian men, but not among men of White or Other race. Note that the relative 
prevalence of factors associated with asthma did not necessarily reflect a factor’s relative 
importance in predicting asthma. For example, among Asians, having ever smoked was much 
more common than obesity, but BMI substantially better explained asthma prevalence than 
smoking status; indeed, smoking status was not among the dominant predictors of asthma at all 
among Asians. Moreover, comparative strengths of associations with asthma did not necessarily 
reflect asthma predictive ability. For example, among Asian women, strengths of association 
with lifetime asthma were similar for ever-smoking, elevated BMI, and having a healthcare 
provider, but only BMI was a dominant asthma predictor. Similarly, obesity was both very 
common and meaningfully associated with asthma among White and Other race men, but BMI 
was not an important explanatory factor for asthma among these sex/racial groups. Thus, if 
asthma interventions at the population level must be focused or prioritized, these findings 
indicate that for women regardless of race, smoking and BMI may be more important than other 
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factors commonly included in asthma prevention efforts (e.g., aspects of healthcare access). For 
male NHOPI and Asian populations, weight management programs could be more influential in 
affecting asthma than smoking cessation efforts. 
 Compared to the eldest age group (>= 65 years), younger White or Asian men (age 18-34 
years) were 80% more likely to report having ever been told they have asthma, whereas middle-
aged were 10% more likely. Age explained over half of lifetime asthma prevalence among White 
men and was both completely and conditionally dominant. Age also best predicted an asthma 
ever-diagnosis for Asian and Other race men but was not a dominant asthma predictor for 
women of any race. Thus, asthma prevention programs may wish to prioritize not only lifestyle-
related asthma risk factors, but also some age groups, in conjunction with the sociodemographic 
contexts of sex and race. 
 Men of Other race were unique in that having a healthcare provider was important in 
predicting asthma prevalence. These findings suggest that asthma may be underestimated 
among men of Other race, given the context that this group reported healthcare coverage and 
provider less frequently, while the outcome of current asthma inherently depends itself on 
accessing healthcare.  
 After statistically controlling for potential confounders using multivariable logistic 
regression, it was found in studies 1 thru 3 that both sex and race continued to modify the 
magnitudes of many asthma associations, including those between measures of SES and asthma 
prevalence. Most notably, significant dose-response declines in asthma prevalence with 
increased levels of SES were consistently observed only among Whites and those of Other race. 
However, dominance analysis by this study found that NHOPI men were the only race/sex 
subpopulation in which education made a relatively greater contribution to the prediction of 
asthma prevalence in comparison to other sociodemographic factors. 
 Although markedly strong associations between asthma prevalence and race have been 
frequently observed in the US (8, 12, 13, 18, 26, 28, 29, 53, 54), this investigation found that 
characteristics other than race better explained heterogeneity in asthma prevalence, regardless 
of SES level. That is, even when associations with asthma prevalence were substantially stronger 
for race than for other sociodemographic factors, race was not a dominant predictor of asthma 
at any level of education attainment.  
 In addition, the most important predictors of asthma prevalence varied by sex and SES. 
For example, among the least educated, the factors of ever-smoking, having a healthcare 
provider, geographic region, BMI, and age better predicted asthma prevalence than did race. 
Specifically, the most dominant covariate among women with less than a high school education 
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was smoking status, which also was conditionally dominant and explained nearly half of asthma. 
Additionally, for women with this lowest education level, BMI remained an important predictor, 
but only for current asthma, less consistently, and to a lesser degree than having a healthcare 
provider. These findings contribute additional insight into asthma among socially disadvantaged 
women, since adjusted prevalence ratios for BMI and healthcare provider were large and nearly 
identical within this subpopulation.  
 But dissimilar to women, smoking status was not an important predictor of asthma 
prevalence among men with lowermost education, despite robust effect sizes for ever-smoking 
in this group. Instead, healthcare provider and region were the two most important covariates 
among men who did not graduate from high school: Those with a healthcare provider were 
nearly twice as likely to report current asthma, with this covariate also explaining nearly 40% of 
current asthma. 
 At higher levels of SES as measured by education, BMI best predicted both lifetime and 
current asthma among women, while age was the only dominant predictor of asthma among 
high school graduate men. Specifically, the most important covariate predictive of asthma 
among high school and college graduate women was BMI, which was conditionally dominant 
and on average explained more than half of current asthma. However, among men who had 
highest levels of education, smoking status, BMI, aspects of healthcare, and/or region were not 
dominant explanatory factors for asthma.  
 For all women and Asian men, asthma prevalence was found in studies 1 and 2 to be 
highest in Hawai‘i and the western region of the US, but geographic region was a dominant 
asthma predictor only for women of NHOPI or Asian race, and only for asthma ever-diagnosis. 
Geographic associations with asthma and their importance were also not uniform across levels 
of SES as represented by education. For example, asthma prevalence was lowest in the South, 
especially among women, but only for those in the middle and upper classes. In contrast, among 
the least educated asthma prevalence was highest in the South, especially for men. Geographic 
region was also a dominant predictor of asthma among men who reported lowest SES (e.g., 
explaining 26% of current asthma). Thus, both the degree of impact and the relative importance 
of regionally-aligned social factors and/or environmental (e.g., climate, air pollution) 
characteristics on asthma prevalence differs by sex, as well as by both race and SES. 
 Taken together, these combined results from multiple regression and dominance 
analyses lend further support for increased recognition that elevated asthma prevalence is 
closely related to preventable factors of social disadvantage. That is, SES plays a complex key 
role in the asthma disparities experienced by NHOPI and other minorities. Moreover, 
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observations that some socially disadvantaged and/or racially-aligned groups within the US 
more often report lack of healthcare coverage, provider, and/or quality (37-40), indicate that 
asthma is potentially under-recognized within these subpopulations. As many others have also 
called for, research and programs for asthma prevention among highly impacted racial/ethnic 
subpopulations should address this interactive relationship between the socio-political (i.e., 
non-biological) constructs of race (70, 71) and SES (19, 24, 46, 48). This would further advance 
needed recognition of the ‘social determinants of health’ (60-65, 67-69): Associations between 
SES markers and preventable diseases such as asthma are both as strong and as important as 
other established disease risk factors having biological basis (e.g., smoking, obesity). 
 Several of the limitations that apply to this investigation have been presented in studies 1 
thru 3, including: Sample size constraints; information bias from the methodology and self-
report of the BRFSS survey; the inherent dependence of the asthma outcome measures on 
healthcare itself; issues surrounding race misclassification that likely bias toward the null; 
implicit constraints on cross-sectional interpretations especially regarding causation; the 
existence of multiple asthma phenotypes with similar symptomology yet disparate aetiologies 
and relationships with SES; unknown bias direction and magnitude from missing data, 
especially for income. 
 Additionally, the results and conclusions of this investigation should be considered 
within the context of other limitations: First, other variables with potentially important roles in 
asthma prevalence disparities were not included in this study due to lack of availability, 
recognition, and/or selection for model inclusion based on statistical significance. Because 
results from dominance analysis depend heavily on a priori model choice, it is necessary to keep 
in mind that covariate relative importance would differ with the inclusion of additional or other 
factors such as other aspects of healthcare, housing characteristics, outdoor/indoor air quality, 
etc. Similarly, this investigation could be improved by comparing dominance analysis results 
from multiple models of asthma prevalence having overlaps in selected covariates. Second, only 
a single measure at one point in time was used to represent SES, which will insufficiently 
capture long-term, multi-faceted, and multi-level asthma-impactful exposures over the life 
course. This is especially relevant for adult asthma outcomes that can have early developmental 
origins and may also depend on compounding of a variety of exposures over time. Inclusion of 
various and/or composite SES measures would better capture the multiple pathways by which 
SES could affect asthma.  However, an advantage to the use of education as a proxy for SES, 
especially in cross-sectional investigations, is that a reversal in causal direction is less likely 
since education is more static after early adulthood and so is less impacted by disease in later 
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adulthood. Third, this investigation did not calculate confidence intervals for the computed 
general dominance metrics, which limited ability to assess the meaningfulness of differences in 
covariates’ predictive contributions to the asthma model. This study could therefore be 
improved by implementing bootstrap analyses to evaluate the reproducibility of the general 
dominance results. 
 Although accompanied by several caveats and limitations, this investigation contributes 
to the understanding of asthma disparities, and is the first study of national-level differences in 
asthma prevalence related to race and/or SES that supplements findings from multiple logistic 
regression with assessments of relative covariate importance using dominance analysis. While 
dominance analysis is a recommended compliment to multiple regression analyses especially for 
observational studies with correlated variables (105), and has been adopted by researches in a 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 5.2. United States, Native Hawaiian/Other Pacific Islander (NHOPI) women 
or men – Sample sizes and sociodemographic weighted population characteristics 
- Behavioral Risk Factor Surveillance System, 2001-2010. 











Total 7,340 100.0 5,135 100.0 
Region: Hawai‘i 4,079 15.1 (14.0,16.2) 2,596 10.8 (9.9,11.7) 
Region: West 1,426 43.1 (39.8,46.3) 1,121 44.6 (41.1,48.1) 
Region: Midwest 414 7.4 (6.3,8.6) 353 11.0 (9.2,13.1) 
Region: Northeast 588 14.3 (12.4,16.5) 436 13.2 (11.2,15.6) 
Region: South 833 20.2 (18.0,22.6) 629 20.5 (18.0,23.1) 
Time period: 2008-2010 2,749 33.1 (30.5,35.7) 1,847 34.2 (31.2,37.4) 
Time period: 2005-2007 2,738 34.3 (31.3,37.4) 1,853 35.4 (32.2,38.7) 
Time period: 2001-2003 1,853 32.6 (29.6,35.8) 1,435 30.4 (27.3,33.7) 
Age: 18-34 years 2,220 46.1 (43.0,49.3) 1,706 52.1 (48.7,55.5) 
Age: 35-64 years 4,036 46.8 (43.7,49.8) 2,746 41.9 (38.6,45.2) 
Age: >=65 years 1,028 7.1 (5.9,8.6) 658 6.0 (4.8,7.5) 
BMI: Obese 2,150 19.6 (17.4,21.9) 1,627 23.2 (20.7,26.0) 
BMI: Overweight 1,961 26.0 (23.4,28.7) 1,810 36.1 (32.8,39.5) 
BMI: Not OW/OB 2,966 54.5 (51.3,57.6) 1,617 40.7 (37.3,44.1) 
Smoke: Ever 3,249 33.3 (30.6,36.1) 2,645 45.0 (41.6,48.4) 
Smoke: Never 4,059 66.7 (63.9,69.4) 2,474 55.0 (51.6,58.4) 
Healthcare coverage: Yes 6,446 85.5 (83.2,87.5) 4,295 77.8 (74.9,80.5) 
Healthcare coverage: No 866 14.5 (12.5,16.8) 804 22.2 (19.5,25.1) 
Healthcare provider: Yes 6,311 82.6 (80.0,85.0) 3,870 69.5 (66.4,72.5) 
Healthcare provider: No 998 17.4 (15.0,20.0) 1,240 30.5 (27.5,33.6) 
Healthcare utilization: Yes 4,526 85.7 (83.2,87.9) 2,822 79.3 (76.3,82.0) 




Table 5.3. United States, Asian women or men – Sample sizes and 
sociodemographic weighted population characteristics - Behavioral Risk Factor 
Surveillance System, 2001-2010. 











Total 33,223 100.0 24,174 100.0 
Region: Hawai‘i 12,855 7.3 (7.0,7.5) 8,504 5.6 (5.4,5.8) 
Region: West 7,010 41.5 (40.2,42.7) 4,737 36.1 (34.8,37.4) 
Region: Midwest 2,742 11.5 (10.9,12.2) 2,230 12.6 (11.9,13.4) 
Region: Northeast 5,524 19.8 (19.0,20.7) 4,898 23.2 (22.2,24.2) 
Region: South 5,092 19.9 (19.0,20.8) 3,805 22.5 (21.4,23.7) 
Time period: 2008-2010 13,424 37.9 (36.8,39.0) 9,563 39.0 (37.7,40.2) 
Time period: 2005-2007 11,576 32.2 (31.0,33.3) 8,071 31.9 (30.7,33.1) 
Time period: 2001-2003 8,223 30.0 (28.8,31.2) 6,540 29.2 (28.0,30.4) 
Age: 18-34 years 8,197 38.7 (37.5,40.0) 6,328 40.7 (39.4,42.1) 
Age: 35-64 years 18,338 51.3 (50.1,52.5) 13,739 51.6 (50.3,52.9) 
Age: >=65 years 6,177 9.9 (9.2,10.7) 3,830 7.7 (7.1,8.3) 
BMI: Obese 2,617 6.4 (5.9,6.9) 2,403 7.8 (7.1,8.5) 
BMI: Overweight 6,845 19.6 (18.6,20.6) 8,514 33.4 (32.2,34.6) 
BMI: Not OW/OB 22,379 74.0 (73.0,75.1) 12,660 58.9 (57.6,60.1) 
Smoke: Ever 6,669 13.4 (12.7,14.1) 9,652 34.4 (33.2,35.6) 
Smoke: Never 26,406 86.6 (85.9,87.3) 14,360 65.6 (64.4,66.8) 
Healthcare coverage: Yes 30,563 88.4 (87.5,89.2) 21,772 86.9 (85.9,87.8) 
Healthcare coverage: No 2,560 11.6 (10.8,12.5) 2,322 13.1 (12.2,14.1) 
Healthcare provider: Yes 28,848 80.6 (79.5,81.7) 19,304 73.8 (72.6,75.0) 
Healthcare provider: No 4,217 19.4 (18.3,20.5) 4,726 26.2 (25.0,27.4) 
Healthcare utilization: Yes 21,412 86.8 (85.9,87.7) 13,935 79.2 (77.8,80.5) 




Table 5.4. United States, White women or men – Sample sizes and 
sociodemographic weighted population characteristics - Behavioral Risk Factor 
Surveillance System, 2001-2010. 











Total 1,586,418 100.0 998,946 100.0 
Region: Hawai‘i 12,957 0.2 (0.2,0.2) 9,979 0.2 (0.2,0.2) 
Region: West 363,451 22.6 (22.5,22.7) 240,638 23.2 (23.0,23.3) 
Region: Midwest 365,912 24.3 (24.2,24.4) 236,104 24.5 (24.3,24.6) 
Region: Northeast 330,013 19.1 (19.0,19.2) 207,151 18.4 (18.3,18.6) 
Region: South 514,085 33.8 (33.7,33.9) 305,074 33.7 (33.6,33.9) 
Time period: 2008-2010 662,233 34.5 (34.4,34.6) 407,932 34.5 (34.4,34.7) 
Time period: 2005-2007 576,466 33.2 (33.0,33.3) 356,941 33.2 (33.0,33.4) 
Time period: 2001-2003 347,719 32.4 (32.2,32.5) 234,073 32.2 (32.1,32.4) 
Age: 18-34 years 221,157 26.5 (26.3,26.6) 148,495 29.4 (29.2,29.6) 
Age: 35-64 years 865,395 52.4 (52.3,52.6) 579,056 54.4 (54.2,54.6) 
Age: >=65 years 485,910 21.1 (21.0,21.2) 266,819 16.3 (16.1,16.4) 
BMI: Obese 334,279 20.4 (20.3,20.5) 240,552 23.0 (22.9,23.2) 
BMI: Overweight 424,393 26.0 (25.9,26.2) 414,508 39.6 (39.4,39.8) 
BMI: Not OW/OB 736,527 53.6 (53.5,53.8) 332,583 37.4 (37.2,37.6) 
Smoke: Ever 698,860 42.0 (41.9,42.2) 554,562 51.9 (51.7,52.1) 
Smoke: Never 880,791 58.0 (57.8,58.1) 440,288 48.1 (47.9,48.3) 
Healthcare coverage: Yes 1,436,795 88.2 (88.1,88.3) 889,069 85.8 (85.6,85.9) 
Healthcare coverage: No 146,697 11.8 (11.7,11.9) 107,035 14.2 (14.1,14.4) 
Healthcare provider: Yes 1,422,568 86.8 (86.7,87.0) 818,747 77.4 (77.2,77.6) 
Healthcare provider: No 159,517 13.2 (13.0,13.3) 176,380 22.6 (22.4,22.8) 
Healthcare utilization: Yes 1,059,122 85.3 (85.2,85.4) 603,191 76.7 (76.5,76.9) 




Table 5.5. United States, Other race women or men – Sample sizes and 
sociodemographic weighted population characteristics - Behavioral Risk Factor 
Surveillance System, 2001-2010. 











Total 273,184 100.0 150,084 100.0 
Region: Hawai‘i 1,767 0.1 (0.1,0.1) 1,366 0.2 (0.2,0.2) 
Region: West 36,833 14.5 (14.2,14.8) 26,905 17.0 (16.6,17.5) 
Region: Midwest 43,334 15.6 (15.3,15.8) 24,105 14.9 (14.6,15.2) 
Region: Northeast 45,329 18.9 (18.6,19.2) 25,077 17.9 (17.5,18.3) 
Region: South 145,921 50.9 (50.5,51.2) 72,631 50.0 (49.5,50.5) 
Time period: 2008-2010 112,028 34.0 (33.7,34.3) 59,432 34.7 (34.2,35.1) 
Time period: 2005-2007 101,789 34.6 (34.3,34.9) 54,562 35.0 (34.5,35.5) 
Time period: 2001-2003 59,367 31.4 (31.1,31.7) 36,090 30.3 (29.9,30.8) 
Age: 18-34 years 64,636 36.9 (36.5,37.2) 35,514 40.6 (40.1,41.2) 
Age: 35-64 years 150,760 50.1 (49.7,50.5) 85,573 49.8 (49.3,50.4) 
Age: >=65 years 52,660 13.1 (12.8,13.3) 26,944 9.5 (9.3,9.8) 
BMI: Obese 90,609 31.4 (31.1,31.8) 41,369 26.6 (26.1,27.0) 
BMI: Overweight 73,836 28.1 (27.8,28.5) 55,353 36.4 (35.9,36.9) 
BMI: Not OW/OB 85,931 40.5 (40.1,40.9) 47,742 37.0 (36.5,37.5) 
Smoke: Ever 99,562 31.5 (31.1,31.8) 79,045 46.7 (46.2,47.2) 
Smoke: Never 172,081 68.5 (68.2,68.9) 69,938 53.3 (52.8,53.8) 
Healthcare coverage: Yes 217,307 76.9 (76.6,77.3) 114,250 70.8 (70.3,71.3) 
Healthcare coverage: No 54,912 23.1 (22.7,23.4) 34,900 29.2 (28.7,29.7) 
Healthcare provider: Yes 225,363 79.2 (78.8,79.5) 106,575 64.3 (63.8,64.8) 
Healthcare provider: No 46,586 20.8 (20.5,21.2) 42,566 35.7 (35.2,36.2) 
Healthcare utilization: Yes 189,931 88.8 (88.5,89.1) 91,891 79.0 (78.5,79.5) 




Table 5.6. Hawai‘i, by Black/African American or American Indian/Alaska Native 
race – Sample sizes and sociodemographic weighted population characteristics - 
Behavioral Risk Factor Surveillance System, 2001-2010. 
Hawai‘i Black/African American  American Indian/ 











Total 585 100.0 292 100.0 
Sex: Female 285 39.3 (34.7,44.1) 168 47.5 (39.7,55.3) 
Sex: Male 300 60.7 (55.9,65.3) 124 52.5 (44.7,60.3) 
Time period: 2008-2010 184 30.4 (26.0,35.1) 83 25.6 (19.5,32.8) 
Time period: 2005-2007 190 32.0 (27.4,36.9) 118 38.0 (30.8,45.7) 
Time period: 2001-2003 211 37.7 (32.9,42.6) 91 36.4 (28.9,44.7) 
Age: 18-34 years 212 48.4 (43.3,53.5) 59 30.0 (23.0,38.2) 
Age: 35-64 years 334 48.7 (43.6,53.7) 182 57.1 (49.1,64.7) 
Age: >=65 years 35 3.0 (2.0,4.4) 50 12.9 (9.2,17.7) 
BMI: Obese 133 25.0 (20.6,30.0) 55 25.3 (18.3,33.8) 
BMI: Overweight 185 32.1 (27.7,36.9) 75 28.2 (21.6,36.0) 
BMI: Not OW/OB 259 42.9 (38.0,48.0) 157 46.5 (38.7,54.4) 
Smoke: Ever 237 35.9 (31.3,40.8) 173 53.3 (45.4,61.0) 
Smoke: Never 347 64.1 (59.2,68.7) 119 46.7 (39.0,54.6) 
Healthcare coverage: Yes 548 95.3 (93.0,96.9) 245 83.4 (76.9,88.3) 
Healthcare coverage: No 37 4.7 (3.1,7.0) 47 16.6 (11.7,23.1) 
Healthcare provider: Yes 474 79.2 (74.5,83.2) 232 77.6 (70.4,83.5) 
Healthcare provider: No 110 20.8 (16.8,25.5) 60 22.4 (16.5,29.6) 
Healthcare utilization: Yes 324 88.7 (84.0,92.2) 151 80.0 (72.4,85.9) 




Table 5.7. Hawai‘i, Native Hawaiian/Other Pacific Islander (NHOPI) women or 
men – Sample sizes and sociodemographic weighted population characteristics - 
Behavioral Risk Factor Surveillance System, 2001-2010. 











Time period: 2008-2010 1,516 38.3 (36.2,40.4) 941 37.8 (35.2,40.6) 
Time period: 2005-2007 1,540 34.7 (32.8,36.7) 930 31.9 (29.5,34.4) 
Time period: 2001-2003 1,023 27.0 (25.2,28.9) 725 30.2 (27.8,32.8) 
Age: 18-34 years 1,113 39.7 (37.4,42.0) 724 45.1 (42.2,47.9) 
Age: 35-64 years 2,253 47.6 (45.4,49.8) 1459 45.1 (42.4,47.8) 
Age: >=65 years 697 12.8 (11.5,14.1) 404 9.9 (8.6,11.3) 
BMI: Obese 1,441 38.2 (36.0,40.4) 1033 42.1 (39.4,44.9) 
BMI: Overweight 1,119 26.4 (24.5,28.4) 841 30.1 (27.7,32.6) 
BMI: Not OW/OB 1,437 35.4 (33.4,37.5) 696 27.8 (25.4,30.3) 
Smoke: Ever 2,007 46.3 (44.2,48.5) 1387 50.3 (47.5,53.0) 
Smoke: Never 2,058 53.7 (51.5,55.8) 1205 49.7 (47.0,52.5) 
Healthcare coverage: Yes 3,775 91.0 (89.4,92.4) 2315 87.2 (85.0,89.1) 
Healthcare coverage: No 299 9.0 (7.6,10.6) 270 12.8 (10.9,15.0) 
Healthcare provider: Yes 3,662 88.0 (86.4,89.5) 2097 76.2 (73.6,78.7) 
Healthcare provider: No 409 12.0 (10.5,13.6) 491 23.8 (21.3,26.4) 
Healthcare utilization: Yes 2,457 80.9 (78.6,83.0) 1415 74.3 (71.1,77.2) 




Table 5.8. Hawai‘i, Asian women or men – Sample sizes and sociodemographic 
weighted population characteristics - Behavioral Risk Factor Surveillance System, 
2001-2010. 











Time period: 2008-2010 4,706 34.4 (33.4,35.4) 3,151 35.0 (33.7,36.3) 
Time period: 2005-2007 4,592 33.4 (32.4,34.3) 2,964 33.3 (32.1,34.6) 
Time period: 2001-2003 3,557 32.2 (31.3,33.2) 2,389 31.7 (30.4,33.0) 
Age: 18-34 years 1,873 24.1 (22.9,25.2) 1,405 30.0 (28.5,31.5) 
Age: 35-64 years 6,736 50.7 (49.6,51.9) 4,751 50.9 (49.5,52.4) 
Age: >=65 years 4,138 25.2 (24.3,26.1) 2,302 19.1 (18.1,20.1) 
BMI: Obese 1,249 10.1 (9.4,10.9) 1,227 14.5 (13.5,15.6) 
BMI: Overweight 2,960 22.5 (21.5,23.4) 3,318 39.2 (37.8,40.6) 
BMI: Not OW/OB 8,276 67.4 (66.3,68.5) 3,897 46.3 (44.9,47.7) 
Smoke: Ever 3,604 26.3 (25.3,27.3) 4,296 47.1 (45.6,48.5) 
Smoke: Never 9,220 73.7 (72.7,74.7) 4,183 52.9 (51.5,54.4) 
Healthcare coverage: Yes 12,387 95.8 (95.2,96.3) 8,014 92.8 (92.0,93.7) 
Healthcare coverage: No 446 4.2 (3.7,4.8) 476 7.2 (6.3,8.0) 
Healthcare provider: Yes 11,981 92.5 (91.8,93.1) 7,434 85.5 (84.3,86.5) 
Healthcare provider: No 851 7.5 (6.9,8.2) 1,047 14.5 (13.5,15.7) 
Healthcare utilization: Yes 7,829 84.4 (83.4,85.5) 4,787 76.4 (74.8,78.0) 




Table 5.9. Hawai‘i, White women or men – Sample sizes and sociodemographic 
weighted population characteristics - Behavioral Risk Factor Surveillance System, 
2001-2010. 











Time period: 2008-2010 4,819 33.4 (32.5,34.4) 3,559 33.4 (32.2,34.6) 
Time period: 2005-2007 4,705 33.4 (32.4,34.4) 3,634 33.2 (32.1,34.4) 
Time period: 2001-2003 3,433 33.2 (32.1,34.2) 2,786 33.4 (32.2,34.6) 
Age: 18-34 years 1,917 26.3 (25.2,27.5) 1,459 28.5 (27.1,29.9) 
Age: 35-64 years 7,929 54.6 (53.5,55.8) 6,195 55.6 (54.2,56.9) 
Age: >=65 years 3,049 19.0 (18.2,19.9) 2,286 16.0 (15.2,16.8) 
BMI: Obese 2,037 16.3 (15.4,17.2) 1,772 18.3 (17.2,19.3) 
BMI: Overweight 2,992 23.2 (22.3,24.3) 3,828 38.8 (37.5,40.1) 
BMI: Not OW/OB 7,652 60.5 (59.3,61.6) 4,293 43.0 (41.6,44.3) 
Smoke: Ever 6,348 45.8 (44.7,47.0) 5,482 51.5 (50.1,52.8) 
Smoke: Never 6,573 54.2 (53.0,55.3) 4,463 48.5 (47.2,49.9) 
Healthcare coverage: Yes 11,972 93.0 (92.3,93.5) 9,043 91.3 (90.5,92.1) 
Healthcare coverage: No 979 7.0 (6.5,7.7) 924 8.7 (7.9,9.5) 
Healthcare provider: Yes 11,158 84.9 (84.0,85.7) 7,902 76.2 (75.0,77.4) 
Healthcare provider: No 1,790 15.1 (14.3,16.0) 2,058 23.8 (22.6,25.0) 
Healthcare utilization: Yes 7,636 82.1 (81.1,83.1) 5,434 76.5 (75.1,77.9) 




Table 5.10. Hawai‘i, Other race women or men – Sample sizes and 
sociodemographic weighted population characteristics - Behavioral Risk Factor 
Surveillance System, 2001-2010. 











Time period: 2008-2010 544 29.8 (27.0,32.6) 445 28.4 (25.5,31.6) 
Time period: 2005-2007 700 35.4 (32.6,38.2) 518 37.2 (33.9,40.6) 
Time period: 2001-2003 523 34.9 (32.0,37.9) 403 34.4 (31.1,37.8) 
Age: 18-34 years 455 38.4 (35.3,41.7) 342 42.7 (39.1,46.5) 
Age: 35-64 years 1,006 51.1 (48.0,54.3) 802 49.5 (45.9,53.1) 
Age: >=65 years 261 10.4 (8.9,12.1) 187 7.8 (6.4,9.4) 
BMI: Obese 318 18.5 (16.2,21.1) 312 27.0 (23.8,30.5) 
BMI: Overweight 407 24.0 (21.5,26.8) 504 37.2 (33.8,40.7) 
BMI: Not OW/OB 944 57.4 (54.3,60.5) 519 35.8 (32.5,39.2) 
Smoke: Ever 693 33.1 (30.4,36.0) 730 48.7 (45.2,52.2) 
Smoke: Never 1,063 66.9 (64.0,69.6) 630 51.3 (47.8,54.8) 
Healthcare coverage: Yes 1,614 92.2 (90.2,93.9) 1,195 88.1 (85.6,90.2) 
Healthcare coverage: No 152 7.8 (6.1,9.8) 163 11.9 (9.8,14.4) 
Healthcare provider: Yes 1,490 84.4 (81.9,86.6) 1,051 75.1 (71.8,78.2) 
Healthcare provider: No 270 15.6 (13.4,18.1) 307 24.9 (21.8,28.2) 
Healthcare utilization: Yes 1,023 84.6 (81.7,87.2) 713 76.7 (72.8,80.1) 




Table 5.11. United States, by Black/African American or American Indian/Alaska 
Native race – Sample sizes and socioeconomic weighted population characteristics 
- Behavioral Risk Factor Surveillance System, 2001-2010. 
United States Black/African American  American Indian/ 











Education: <High school  42,873 15.1 (14.9,15.4) 10,385 23.0 (22.1,24.0) 
Education: High school  150,630 62.2 (61.8,62.6) 32,115 60.6 (59.6,61.7) 
Education: College 55,431 22.6 (22.3,23.0) 9,167 16.3 (15.6,17.1) 
Household income:  Missing 34,413 13.7 (13.5,14.0) 6,157 12.4 (11.7,13.2) 
Household income: <$15K 47,475 15.5 (15.2,15.7) 10,832 17.3 (16.5,18.1) 
Household income: <$25K 54,868 20.3 (20.0,20.6) 12,077 21.3 (20.5,22.2) 
Household income: <$35K 32,895 13.1 (12.8,13.3) 6,605 12.9 (12.2,13.6) 
Household income: <$50K 31,082 13.2 (13.0,13.5) 6,445 13.6 (12.8,14.4) 
Household income: <$75K 24,310 11.1 (10.9,11.3) 4,994 10.7 (10.1,11.4) 
Household income: ≥$75K 24,874 13.1 (12.8,13.4) 4,727 11.8 (11.1,12.5) 
Individual income: Missing 34,612 13.8 (13.6,14.1) 6,190 12.5 (11.7,13.2) 
Individual income: <$5K 32,118 16.8 (16.5,17.1) 8,924 21.6 (20.7,22.6) 
Individual income: <$10K 48,343 19.5 (19.2,19.8) 11,336 21.6 (20.8,22.6) 
Individual income: <$15K 34,713 14.5 (14.2,14.7) 7,579 14.7 (13.9,15.5) 
Individual income: <$20K 29,070 12.3 (12.1,12.6) 5,704 10.7 (10.1,11.3) 
Individual income: <$35K 44,362 15.5 (15.2,15.7) 8,205 13.2 (12.6,13.8) 
Individual income: ≥$35K 26,699 7.7 (7.5,7.8) 3,899 5.7 (5.3,6.1) 
PIR: Missing 34,613 13.8 (13.6,14.1) 6,194 12.5 (11.8,13.3) 
PIR: <1 49,098 20.2 (19.9,20.5) 12,407 24.5 (23.5,25.5) 
PIR: <2 62,025 24.1 (23.7,24.4) 13,744 25.6 (24.6,26.5) 
PIR: <3 40,579 15.9 (15.6,16.2) 8,152 15.8 (15.0,16.6) 
PIR: >=3 63,602 26.0 (25.7,26.4) 11,340 21.7 (20.9,22.5) 
Composite SES: Missing 34,894 14.0 (13.7,14.2) 6,252 12.7 (12.0,13.5) 
Composite SES: Low 26,902 9.6 (9.3,9.8) 6,866 15.5 (14.7,16.3) 
Composite SES: Mid 147,191 59.9 (59.5,60.3) 32,612 61.0 (59.9,62.0) 
Composite SES: High 40,930 16.6 (16.3,16.8) 6,107 10.9 (10.3,11.4) 
Employment: Unemployed 51,990 19.4 (19.1,19.7) 11,592 20.0 (19.1,20.8) 
Employment: Other 66,494 22.4 (22.0,22.7) 13,419 23.5 (22.6,24.4) 
Employment: Employed 130,151 58.2 (57.8,58.6) 26,594 56.6 (55.5,57.7) 
Healthcare cost barrier: Yes 37,067 20.1 (19.8,20.5) 8,378 23.2 (22.1,24.3) 




Table 5.12. United States, Native Hawaiian/Other Pacific Islander (NHOPI) women 
or men – Sample sizes and socioeconomic weighted population characteristics - 
Behavioral Risk Factor Surveillance System, 2001-2010. 











Education: <High school  651 10.8 (8.6,13.5) 475 11.1 (9.1,13.6) 
Education: High school  4,899 60.3 (57.2,63.3) 3,403 59.4 (56.0,62.7) 
Education: College 1,770 28.9 (26.3,31.7) 1,241 29.5 (26.5,32.6) 
Household income:  Missing 945 12.7 (11.0,14.6) 672 13.1 (10.8,15.9) 
Household income: <$15K 912 10.5 (8.7,12.7) 468 9.2 (7.3,11.5) 
Household income: <$25K 1,298 15.8 (13.6,18.2) 804 14.8 (12.7,17.2) 
Household income: <$35K 903 12.1 (10.2,14.3) 608 11.8 (9.8,14.2) 
Household income: <$50K 1,088 13.4 (11.5,15.6) 816 14.4 (12.1,17.0) 
Household income: <$75K 991 13.5 (11.7,15.4) 762 14.0 (11.9,16.4) 
Household income: ≥$75K 1,203 22.1 (19.4,24.9) 1,005 22.7 (20.1,25.5) 
Individual income: Missing 949 12.7 (11.0,14.6) 679 13.3 (10.9,16.1) 
Individual income: <$5K 1,022 17.7 (15.2,20.6) 517 15.7 (13.2,18.6) 
Individual income: <$10K 1,371 17.1 (14.8,19.8) 851 19.3 (16.7,22.3) 
Individual income: <$15K 1,159 16.0 (13.8,18.4) 802 13.4 (11.4,15.8) 
Individual income: <$20K 1,035 16.8 (14.7,19.2) 756 15.1 (12.9,17.6) 
Individual income: <$35K 1,198 13.7 (11.9,15.6) 929 15.1 (12.9,17.4) 
Individual income: ≥$35K 606 6.1 (5.1,7.2) 601 8.0 (6.7,9.6) 
PIR: Missing 950 12.7 (11.0,14.6) 681 13.7 (11.2,16.5) 
PIR: <1 1,365 18.8 (16.2,21.6) 703 16.5 (14.1,19.3) 
PIR: <2 1,813 20.1 (17.9,22.5) 1,192 22.2 (19.5,25.2) 
PIR: <3 1,403 19.3 (16.8,22.1) 994 15.3 (13.2,17.6) 
PIR: >=3 1,809 29.1 (26.5,31.9) 1,565 32.3 (29.3,35.5) 
Composite SES: Missing 952 12.7 (11.1,14.7) 686 13.9 (11.5,16.7) 
Composite SES: Low 417 7.3 (5.4,9.7) 294 7.6 (5.9,9.8) 
Composite SES: Mid 4,701 58.6 (55.6,61.6) 3,238 58.3 (54.9,61.6) 
Composite SES: High 1,270 21.3 (19.0,23.8) 917 20.2 (17.8,22.9) 
Employment: Unemployed 858 14.4 (12.1,17.1) 699 15.2 (12.9,17.9) 
Employment: Other 2,168 27.4 (24.8,30.2) 961 15.9 (13.7,18.3) 
Employment: Employed 4,283 58.1 (55.0,61.2) 3,450 68.9 (65.7,71.9) 
Healthcare cost barrier: Yes 818 18.2 (15.6,21.2) 466 16.0 (13.4,19.0) 




Table 5.13. United States, Asian women or men – Sample sizes and socioeconomic 
weighted population characteristics - Behavioral Risk Factor Surveillance System, 
2001-2010. 












Education: <High school  1,877 5.5 (4.9,6.1) 1,020 4.5 (3.9,5.1) 
Education: High school  13,784 35.9 (34.7,37.1) 9,021 31.9 (30.6,33.1) 
Education: College 17,357 58.6 (57.4,59.8) 14,019 63.7 (62.4,65.0) 
Household income:  Missing 5,704 15.5 (14.6,16.4) 2,877 10.9 (10.1,11.7) 
Household income: <$15K 2,499 8.9 (8.1,9.7) 1,350 7.0 (6.3,7.8) 
Household income: <$25K 3,641 9.9 (9.2,10.7) 2,384 9.5 (8.8,10.4) 
Household income: <$35K 3,077 7.7 (7.1,8.4) 2,206 7.8 (7.2,8.5) 
Household income: <$50K 4,267 11.9 (11.1,12.7) 3,197 11.7 (10.8,12.6) 
Household income: <$75K 4,693 13.6 (12.8,14.4) 3,935 15.2 (14.3,16.2) 
Household income: ≥$75K 9,342 32.5 (31.4,33.6) 8,225 37.8 (36.6,39.1) 
Individual income: Missing 5,728 15.6 (14.7,16.5) 2,905 11.0 (10.3,11.8) 
Individual income: <$5K 2,054 10.5 (9.6,11.5) 1,315 9.6 (8.8,10.6) 
Individual income: <$10K 3,665 12.4 (11.5,13.3) 2,499 12.2 (11.3,13.1) 
Individual income: <$15K 4,108 13.4 (12.5,14.2) 2,855 12.8 (11.9,13.8) 
Individual income: <$20K 5,763 19.8 (18.9,20.8) 4,568 22.6 (21.5,23.7) 
Individual income: <$35K 7,115 18.3 (17.5,19.2) 5,626 19.8 (18.8,20.8) 
Individual income: ≥$35K 4,790 10.0 (9.5,10.6) 4,406 12.0 (11.4,12.7) 
PIR: Missing 5,729 15.6 (14.7,16.5) 2,905 11.0 (10.3,11.8) 
PIR: <1 3,044 12.1 (11.2,13.0) 1,842 10.8 (9.9,11.8) 
PIR: <2 5,429 14.7 (13.8,15.6) 3,629 14.3 (13.4,15.3) 
PIR: <3 5,643 16.0 (15.2,17.0) 4,084 15.7 (14.7,16.7) 
PIR: >=3 13,378 41.6 (40.5,42.8) 11,714 48.2 (46.9,49.5) 
Composite SES: Missing 5,780 15.7 (14.8,16.6) 2,931 11.1 (10.4,11.9) 
Composite SES: Low 1,051 3.5 (3.1,4.0) 568 2.6 (2.2,3.1) 
Composite SES: Mid 13,795 39.5 (38.3,40.8) 9,664 38.0 (36.7,39.3) 
Composite SES: High 12,597 41.2 (40.1,42.4) 11,011 48.3 (47.0,49.6) 
Employment: Unemployed 2,187 8.6 (7.8,9.4) 1,595 7.8 (7.1,8.5) 
Employment: Other 11,869 33.6 (32.4,34.8) 5,204 18.8 (17.7,19.9) 
Employment: Employed 18,987 57.8 (56.6,59.0) 17,249 73.4 (72.2,74.6) 
Healthcare cost barrier: Yes 2,185 11.7 (10.8,12.6) 1,443 10.8 (9.8,12.0) 




Table 5.14. United States, White women or men – Sample sizes and socioeconomic 
weighted population characteristics - Behavioral Risk Factor Surveillance System, 
2001-2010. 












Education: <High school  136,570 10.0 (9.9,10.1) 83,877 10.1 (10.0,10.3) 
Education: High school  942,650 58.1 (57.9,58.2) 539,016 54.2 (54.0,54.3) 
Education: College 503,473 31.9 (31.8,32.1) 373,775 35.7 (35.6,35.9) 
Household income:  Missing 249,378 15.1 (15.0,15.3) 99,918 10.3 (10.2,10.4) 
Household income: <$15K 158,329 9.0 (8.9,9.1) 64,045 6.3 (6.2,6.4) 
Household income: <$25K 246,309 13.7 (13.6,13.8) 125,920 11.9 (11.7,12.0) 
Household income: <$35K 177,533 10.4 (10.3,10.5) 112,453 10.5 (10.3,10.6) 
Household income: <$50K 221,265 13.6 (13.5,13.7) 157,005 14.5 (14.4,14.7) 
Household income: <$75K 224,604 14.9 (14.8,15.0) 169,446 16.8 (16.6,16.9) 
Household income: ≥$75K 309,000 23.2 (23.0,23.3) 270,159 29.8 (29.6,30.0) 
Individual income: Missing 250,371 15.2 (15.1,15.3) 100,606 10.4 (10.3,10.5) 
Individual income: <$5K 69,467 8.1 (7.9,8.2) 31,829 7.0 (6.8,7.1) 
Individual income: <$10K 175,255 12.4 (12.3,12.5) 94,472 11.5 (11.4,11.6) 
Individual income: <$15K 205,357 13.6 (13.5,13.7) 123,070 13.6 (13.5,13.8) 
Individual income: <$20K 245,641 17.3 (17.2,17.5) 165,684 19.0 (18.9,19.2) 
Individual income: <$35K 391,849 21.7 (21.6,21.8) 272,022 23.5 (23.4,23.7) 
Individual income: ≥$35K 248,478 11.7 (11.6,11.8) 211,263 15.0 (14.9,15.1) 
PIR: Missing 250,375 15.2 (15.1,15.3) 100,607 10.4 (10.3,10.5) 
PIR: <1 127,297 10.1 (10.0,10.2) 56,239 8.3 (8.1,8.4) 
PIR: <2 286,520 17.5 (17.3,17.6) 151,617 15.8 (15.7,16.0) 
PIR: <3 293,995 17.0 (16.9,17.2) 185,595 17.4 (17.2,17.5) 
PIR: >=3 628,231 40.2 (40.0,40.3) 504,888 48.2 (48.0,48.4) 
Composite SES: Missing 251,299 15.3 (15.2,15.4) 101,305 10.5 (10.3,10.6) 
Composite SES: Low 76,545 6.0 (5.9,6.1) 43,533 6.0 (5.8,6.1) 
Composite SES: Mid 862,094 53.5 (53.3,53.6) 541,285 53.8 (53.6,54.0) 
Composite SES: High 396,480 25.2 (25.1,25.4) 312,823 29.8 (29.6,29.9) 
Employment: Unemployed 151,464 9.4 (9.3,9.5) 91,923 9.6 (9.5,9.7) 
Employment: Other 646,911 37.9 (37.7,38.0) 286,481 21.6 (21.4,21.7) 
Employment: Employed 783,133 52.7 (52.6,52.9) 617,674 68.8 (68.7,69.0) 
Healthcare cost barrier: Yes 142,509 13.9 (13.8,14.1) 64,139 10.5 (10.3,10.6) 




Table 5.15. United States, Other race women or men – Sample sizes and 
socioeconomic weighted population characteristics - Behavioral Risk Factor 
Surveillance System, 2001-2010. 
United States Other  
Women 














Education: <High school  54,295 19.1 (18.8,19.4) 31,381 21.2 (20.8,21.6) 
Education: High school  158,320 59.0 (58.6,59.4) 84,571 58.3 (57.8,58.8) 
Education: College 58,947 21.9 (21.6,22.2) 33,098 20.5 (20.1,20.9) 
Household income:  Missing 44,693 16.1 (15.8,16.4) 20,971 14.1 (13.8,14.5) 
Household income: <$15K 55,378 17.6 (17.3,17.9) 21,531 12.6 (12.3,13.0) 
Household income: <$25K 61,879 21.4 (21.1,21.7) 31,985 21.3 (20.9,21.7) 
Household income: <$35K 33,797 12.5 (12.3,12.8) 19,761 13.0 (12.6,13.3) 
Household income: <$50K 30,904 12.1 (11.9,12.4) 19,870 13.2 (12.9,13.6) 
Household income: <$75K 23,490 9.6 (9.4,9.9) 16,356 11.2 (10.9,11.5) 
Household income: ≥$75K 23,043 10.6 (10.3,10.8) 19,610 14.5 (14.2,14.9) 
Individual income: Missing 44,968 16.2 (15.9,16.5) 21,184 14.3 (13.9,14.6) 
Individual income: <$5K 43,225 20.5 (20.1,20.8) 17,494 17.8 (17.3,18.2) 
Individual income: <$10K 55,432 20.3 (20.0,20.6) 27,428 19.7 (19.3,20.1) 
Individual income: <$15K 36,392 13.6 (13.3,13.8) 20,795 14.2 (13.8,14.5) 
Individual income: <$20K 28,509 10.4 (10.2,10.7) 18,437 12.5 (12.2,12.8) 
Individual income: <$35K 41,806 13.1 (12.9,13.3) 27,290 14.3 (14.0,14.6) 
Individual income: ≥$35K 22,852 5.9 (5.8,6.1) 17,456 7.3 (7.1,7.5) 
PIR: Missing 44,970 16.2 (15.9,16.5) 21,189 14.3 (13.9,14.6) 
PIR: <1 61,376 23.8 (23.4,24.1) 24,996 20.1 (19.6,20.5) 
PIR: <2 68,424 24.4 (24.1,24.8) 35,851 24.1 (23.7,24.5) 
PIR: <3 40,259 14.2 (14.0,14.5) 24,820 15.4 (15.1,15.8) 
PIR: >=3 58,155 21.4 (21.1,21.7) 43,228 26.1 (25.7,26.6) 
Composite SES: Missing 45,334 16.4 (16.1,16.6) 21,499 14.5 (14.1,14.9) 
Composite SES: Low 34,812 12.4 (12.2,12.7) 20,234 14.2 (13.9,14.6) 
Composite SES: Mid 152,803 56.3 (56.0,56.7) 84,482 56.6 (56.1,57.1) 
Composite SES: High 40,235 14.9 (14.6,15.1) 23,869 14.6 (14.3,15.0) 
Employment: Unemployed 53,964 17.7 (17.4,18.0) 27,498 17.4 (17.0,17.8) 
Employment: Other 81,273 29.1 (28.8,29.5) 32,690 16.4 (16.0,16.7) 
Employment: Employed 136,060 53.1 (52.8,53.5) 88,800 66.2 (65.7,66.7) 
Healthcare cost barrier: Yes 46,385 23.7 (23.4,24.1) 19,451 19.8 (19.3,20.3) 
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